MTD 10-Q Quarterly Report Sept. 30, 2022 | Alphaminr
METTLER TOLEDO INTERNATIONAL INC/
ALPHAMINR

MTD 10-Q Quarter ended Sept. 30, 2022

Balance Sheet
Cash Flow
Income Statement
Debt
METTLER TOLEDO INTERNATIONAL INC/
10-Ks and 10-Qs
10-Q
Quarter ended Sept. 30, 2025
10-Q
Quarter ended June 30, 2025
10-Q
Quarter ended March 31, 2025
10-K
Fiscal year ended Dec. 31, 2024
10-Q
Quarter ended Sept. 30, 2024
10-Q
Quarter ended June 30, 2024
10-Q
Quarter ended March 31, 2024
10-K
Fiscal year ended Dec. 31, 2023
10-Q
Quarter ended Sept. 30, 2023
10-Q
Quarter ended June 30, 2023
10-Q
Quarter ended March 31, 2023
10-K
Fiscal year ended Dec. 31, 2022
10-Q
Quarter ended Sept. 30, 2022
10-Q
Quarter ended June 30, 2022
10-Q
Quarter ended March 31, 2022
10-K
Fiscal year ended Dec. 31, 2021
10-Q
Quarter ended Sept. 30, 2021
10-Q
Quarter ended June 30, 2021
10-Q
Quarter ended March 31, 2021
10-K
Fiscal year ended Dec. 31, 2020
10-Q
Quarter ended Sept. 30, 2020
10-Q
Quarter ended June 30, 2020
10-Q
Quarter ended March 31, 2020
10-K
Fiscal year ended Dec. 31, 2019
10-Q
Quarter ended Sept. 30, 2019
10-Q
Quarter ended June 30, 2019
10-Q
Quarter ended March 31, 2019
10-K
Fiscal year ended Dec. 31, 2018
10-Q
Quarter ended Sept. 30, 2018
10-Q
Quarter ended June 30, 2018
10-Q
Quarter ended March 31, 2018
10-K
Fiscal year ended Dec. 31, 2017
10-Q
Quarter ended Sept. 30, 2017
10-Q
Quarter ended June 30, 2017
10-Q
Quarter ended March 31, 2017
10-K
Fiscal year ended Dec. 31, 2016
10-Q
Quarter ended Sept. 30, 2016
10-Q
Quarter ended June 30, 2016
10-Q
Quarter ended March 31, 2016
10-K
Fiscal year ended Dec. 31, 2015
10-Q
Quarter ended Sept. 30, 2015
10-Q
Quarter ended June 30, 2015
10-Q
Quarter ended March 31, 2015
10-K
Fiscal year ended Dec. 31, 2014
10-Q
Quarter ended Sept. 30, 2014
10-Q
Quarter ended June 30, 2014
10-Q
Quarter ended March 31, 2014
10-K
Fiscal year ended Dec. 31, 2013
10-Q
Quarter ended Sept. 30, 2013
10-Q
Quarter ended June 30, 2013
10-Q
Quarter ended March 31, 2013
10-K
Fiscal year ended Dec. 31, 2012
10-Q
Quarter ended Sept. 30, 2012
10-Q
Quarter ended June 30, 2012
10-Q
Quarter ended March 31, 2012
10-K
Fiscal year ended Dec. 31, 2011
10-Q
Quarter ended Sept. 30, 2011
10-Q
Quarter ended June 30, 2011
10-Q
Quarter ended March 31, 2011
10-K
Fiscal year ended Dec. 31, 2010
10-Q
Quarter ended Sept. 30, 2010
10-Q
Quarter ended June 30, 2010
10-Q
Quarter ended March 31, 2010
10-K
Fiscal year ended Dec. 31, 2009
PROXIES
DEF 14A
Filed on May 1, 2025
DEF 14A
Filed on March 17, 2025
DEF 14A
Filed on May 9, 2024
DEF 14A
Filed on March 19, 2024
DEF 14A
Filed on March 15, 2023
DEF 14A
Filed on May 5, 2022
DEF 14A
Filed on March 15, 2022
DEF 14A
Filed on March 15, 2021
DEF 14A
Filed on March 16, 2020
DEF 14A
Filed on March 15, 2019
DEF 14A
Filed on March 15, 2018
DEF 14A
Filed on March 15, 2017
DEF 14A
Filed on March 15, 2016
DEF 14A
Filed on March 16, 2015
DEF 14A
Filed on March 17, 2014
DEF 14A
Filed on March 15, 2013
DEF 14A
Filed on March 15, 2012
DEF 14A
Filed on March 22, 2011
DEF 14A
Filed on March 15, 2010
mtd-20220930
0001037646 12/31 2021 Q3 FALSE 22,094 22,176 0.01 0.01 10,000,000 10,000,000 0.01 0.01 125,000,000 125,000,000 44,786,011 44,786,011 22,294,189 22,843,103 22,491,822 21,942,908 — — — — — — — — — — — — 4.24 June 25, 2025 125,000 10.0 3.67 December 17, 2022 50,000 10.0 4.10 September 19, 2023 50,000 10.0 3.84 September 19, 2024 125,000 10.0 3.91 June 25, 2029 75,000 10.0 3.19 January 24, 2035 50,000 15.0 1.47 June 17, 2030 125,000 15.0 1.3 November 6, 2034 135,000 15.0 2.83 July 22, 2033 125,000 12.0 0.975 June 15, 2023 1,250,000 2.81 March 27, 2037 150,000 15.0 2.91 September 1, 2037 150,000 15.0 0.85 0001037646 2022-01-01 2022-09-30 0001037646 2022-09-30 xbrli:shares 0001037646 us-gaap:ProductMember 2022-07-01 2022-09-30 iso4217:USD 0001037646 us-gaap:ProductMember 2021-07-01 2021-09-30 0001037646 us-gaap:ServiceMember 2022-07-01 2022-09-30 0001037646 us-gaap:ServiceMember 2021-07-01 2021-09-30 0001037646 2022-07-01 2022-09-30 0001037646 2021-07-01 2021-09-30 iso4217:USD xbrli:shares 0001037646 us-gaap:ProductMember 2022-01-01 2022-09-30 0001037646 us-gaap:ProductMember 2021-01-01 2021-09-30 0001037646 us-gaap:ServiceMember 2022-01-01 2022-09-30 0001037646 us-gaap:ServiceMember 2021-01-01 2021-09-30 0001037646 2021-01-01 2021-09-30 0001037646 2021-12-31 0001037646 us-gaap:CommonStockMember 2020-12-31 0001037646 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001037646 us-gaap:TreasuryStockMember 2020-12-31 0001037646 us-gaap:RetainedEarningsMember 2020-12-31 0001037646 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001037646 2020-12-31 0001037646 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001037646 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001037646 us-gaap:TreasuryStockMember 2021-01-01 2021-03-31 0001037646 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001037646 2021-01-01 2021-03-31 0001037646 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001037646 us-gaap:CommonStockMember 2021-03-31 0001037646 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001037646 us-gaap:TreasuryStockMember 2021-03-31 0001037646 us-gaap:RetainedEarningsMember 2021-03-31 0001037646 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001037646 2021-03-31 0001037646 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001037646 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001037646 us-gaap:TreasuryStockMember 2021-04-01 2021-06-30 0001037646 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001037646 2021-04-01 2021-06-30 0001037646 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0001037646 us-gaap:CommonStockMember 2021-06-30 0001037646 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001037646 us-gaap:TreasuryStockMember 2021-06-30 0001037646 us-gaap:RetainedEarningsMember 2021-06-30 0001037646 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001037646 2021-06-30 0001037646 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001037646 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001037646 us-gaap:TreasuryStockMember 2021-07-01 2021-09-30 0001037646 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001037646 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001037646 us-gaap:CommonStockMember 2021-09-30 0001037646 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001037646 us-gaap:TreasuryStockMember 2021-09-30 0001037646 us-gaap:RetainedEarningsMember 2021-09-30 0001037646 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001037646 2021-09-30 0001037646 us-gaap:CommonStockMember 2021-12-31 0001037646 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001037646 us-gaap:TreasuryStockMember 2021-12-31 0001037646 us-gaap:RetainedEarningsMember 2021-12-31 0001037646 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001037646 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001037646 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001037646 us-gaap:TreasuryStockMember 2022-01-01 2022-03-31 0001037646 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001037646 2022-01-01 2022-03-31 0001037646 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001037646 us-gaap:CommonStockMember 2022-03-31 0001037646 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001037646 us-gaap:TreasuryStockMember 2022-03-31 0001037646 us-gaap:RetainedEarningsMember 2022-03-31 0001037646 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001037646 2022-03-31 0001037646 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001037646 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001037646 us-gaap:TreasuryStockMember 2022-04-01 2022-06-30 0001037646 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001037646 2022-04-01 2022-06-30 0001037646 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001037646 us-gaap:CommonStockMember 2022-06-30 0001037646 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001037646 us-gaap:TreasuryStockMember 2022-06-30 0001037646 us-gaap:RetainedEarningsMember 2022-06-30 0001037646 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001037646 2022-06-30 0001037646 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001037646 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001037646 us-gaap:TreasuryStockMember 2022-07-01 2022-09-30 0001037646 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001037646 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0001037646 us-gaap:CommonStockMember 2022-09-30 0001037646 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001037646 us-gaap:TreasuryStockMember 2022-09-30 0001037646 us-gaap:RetainedEarningsMember 2022-09-30 0001037646 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001037646 us-gaap:CustomerRelationshipsMember 2022-09-30 0001037646 us-gaap:CustomerRelationshipsMember 2021-12-31 0001037646 mtd:ProvenTechnologyAndPatentsMember 2022-09-30 0001037646 mtd:ProvenTechnologyAndPatentsMember 2021-12-31 0001037646 us-gaap:TradeNamesMember 2022-09-30 0001037646 us-gaap:TradeNamesMember 2021-12-31 0001037646 us-gaap:TradeNamesMember 2022-09-30 0001037646 us-gaap:TradeNamesMember 2021-12-31 0001037646 us-gaap:OtherIntangibleAssetsMember 2022-09-30 0001037646 us-gaap:OtherIntangibleAssetsMember 2021-12-31 0001037646 us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember mtd:USOperationsMember 2022-07-01 2022-09-30 0001037646 mtd:SwissOperationsMember us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember 2022-07-01 2022-09-30 0001037646 us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember mtd:WesternEuropeanOperationsMember 2022-07-01 2022-09-30 0001037646 mtd:ChineseOperationsMember us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember 2022-07-01 2022-09-30 0001037646 us-gaap:ProductMember mtd:OtherOperationsMember us-gaap:TransferredAtPointInTimeMember 2022-07-01 2022-09-30 0001037646 us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember 2022-07-01 2022-09-30 0001037646 us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember mtd:USOperationsMember 2022-07-01 2022-09-30 0001037646 mtd:SwissOperationsMember us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember 2022-07-01 2022-09-30 0001037646 us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember mtd:WesternEuropeanOperationsMember 2022-07-01 2022-09-30 0001037646 mtd:ChineseOperationsMember us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember 2022-07-01 2022-09-30 0001037646 us-gaap:ServiceMember mtd:OtherOperationsMember us-gaap:TransferredAtPointInTimeMember 2022-07-01 2022-09-30 0001037646 us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember 2022-07-01 2022-09-30 0001037646 us-gaap:ServiceMember mtd:USOperationsMember us-gaap:TransferredOverTimeMember 2022-07-01 2022-09-30 0001037646 mtd:SwissOperationsMember us-gaap:ServiceMember us-gaap:TransferredOverTimeMember 2022-07-01 2022-09-30 0001037646 us-gaap:ServiceMember mtd:WesternEuropeanOperationsMember us-gaap:TransferredOverTimeMember 2022-07-01 2022-09-30 0001037646 mtd:ChineseOperationsMember us-gaap:ServiceMember us-gaap:TransferredOverTimeMember 2022-07-01 2022-09-30 0001037646 us-gaap:ServiceMember mtd:OtherOperationsMember us-gaap:TransferredOverTimeMember 2022-07-01 2022-09-30 0001037646 us-gaap:ServiceMember us-gaap:TransferredOverTimeMember 2022-07-01 2022-09-30 0001037646 mtd:USOperationsMember 2022-07-01 2022-09-30 0001037646 mtd:SwissOperationsMember 2022-07-01 2022-09-30 0001037646 mtd:WesternEuropeanOperationsMember 2022-07-01 2022-09-30 0001037646 mtd:ChineseOperationsMember 2022-07-01 2022-09-30 0001037646 mtd:OtherOperationsMember 2022-07-01 2022-09-30 0001037646 us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember mtd:USOperationsMember 2021-07-01 2021-09-30 0001037646 mtd:SwissOperationsMember us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember 2021-07-01 2021-09-30 0001037646 us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember mtd:WesternEuropeanOperationsMember 2021-07-01 2021-09-30 0001037646 mtd:ChineseOperationsMember us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember 2021-07-01 2021-09-30 0001037646 us-gaap:ProductMember mtd:OtherOperationsMember us-gaap:TransferredAtPointInTimeMember 2021-07-01 2021-09-30 0001037646 us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember 2021-07-01 2021-09-30 0001037646 us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember mtd:USOperationsMember 2021-07-01 2021-09-30 0001037646 mtd:SwissOperationsMember us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember 2021-07-01 2021-09-30 0001037646 us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember mtd:WesternEuropeanOperationsMember 2021-07-01 2021-09-30 0001037646 mtd:ChineseOperationsMember us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember 2021-07-01 2021-09-30 0001037646 us-gaap:ServiceMember mtd:OtherOperationsMember us-gaap:TransferredAtPointInTimeMember 2021-07-01 2021-09-30 0001037646 us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember 2021-07-01 2021-09-30 0001037646 us-gaap:ServiceMember mtd:USOperationsMember us-gaap:TransferredOverTimeMember 2021-07-01 2021-09-30 0001037646 mtd:SwissOperationsMember us-gaap:ServiceMember us-gaap:TransferredOverTimeMember 2021-07-01 2021-09-30 0001037646 us-gaap:ServiceMember mtd:WesternEuropeanOperationsMember us-gaap:TransferredOverTimeMember 2021-07-01 2021-09-30 0001037646 mtd:ChineseOperationsMember us-gaap:ServiceMember us-gaap:TransferredOverTimeMember 2021-07-01 2021-09-30 0001037646 us-gaap:ServiceMember mtd:OtherOperationsMember us-gaap:TransferredOverTimeMember 2021-07-01 2021-09-30 0001037646 us-gaap:ServiceMember us-gaap:TransferredOverTimeMember 2021-07-01 2021-09-30 0001037646 mtd:USOperationsMember 2021-07-01 2021-09-30 0001037646 mtd:SwissOperationsMember 2021-07-01 2021-09-30 0001037646 mtd:WesternEuropeanOperationsMember 2021-07-01 2021-09-30 0001037646 mtd:ChineseOperationsMember 2021-07-01 2021-09-30 0001037646 mtd:OtherOperationsMember 2021-07-01 2021-09-30 0001037646 us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember mtd:USOperationsMember 2022-01-01 2022-09-30 0001037646 mtd:SwissOperationsMember us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-09-30 0001037646 us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember mtd:WesternEuropeanOperationsMember 2022-01-01 2022-09-30 0001037646 mtd:ChineseOperationsMember us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-09-30 0001037646 us-gaap:ProductMember mtd:OtherOperationsMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-09-30 0001037646 us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-09-30 0001037646 us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember mtd:USOperationsMember 2022-01-01 2022-09-30 0001037646 mtd:SwissOperationsMember us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-09-30 0001037646 us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember mtd:WesternEuropeanOperationsMember 2022-01-01 2022-09-30 0001037646 mtd:ChineseOperationsMember us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-09-30 0001037646 us-gaap:ServiceMember mtd:OtherOperationsMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-09-30 0001037646 us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember 2022-01-01 2022-09-30 0001037646 us-gaap:ServiceMember mtd:USOperationsMember us-gaap:TransferredOverTimeMember 2022-01-01 2022-09-30 0001037646 mtd:SwissOperationsMember us-gaap:ServiceMember us-gaap:TransferredOverTimeMember 2022-01-01 2022-09-30 0001037646 us-gaap:ServiceMember mtd:WesternEuropeanOperationsMember us-gaap:TransferredOverTimeMember 2022-01-01 2022-09-30 0001037646 mtd:ChineseOperationsMember us-gaap:ServiceMember us-gaap:TransferredOverTimeMember 2022-01-01 2022-09-30 0001037646 us-gaap:ServiceMember mtd:OtherOperationsMember us-gaap:TransferredOverTimeMember 2022-01-01 2022-09-30 0001037646 us-gaap:ServiceMember us-gaap:TransferredOverTimeMember 2022-01-01 2022-09-30 0001037646 mtd:USOperationsMember 2022-01-01 2022-09-30 0001037646 mtd:SwissOperationsMember 2022-01-01 2022-09-30 0001037646 mtd:WesternEuropeanOperationsMember 2022-01-01 2022-09-30 0001037646 mtd:ChineseOperationsMember 2022-01-01 2022-09-30 0001037646 mtd:OtherOperationsMember 2022-01-01 2022-09-30 0001037646 us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember mtd:USOperationsMember 2021-01-01 2021-09-30 0001037646 mtd:SwissOperationsMember us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-09-30 0001037646 us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember mtd:WesternEuropeanOperationsMember 2021-01-01 2021-09-30 0001037646 mtd:ChineseOperationsMember us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-09-30 0001037646 us-gaap:ProductMember mtd:OtherOperationsMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-09-30 0001037646 us-gaap:ProductMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-09-30 0001037646 us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember mtd:USOperationsMember 2021-01-01 2021-09-30 0001037646 mtd:SwissOperationsMember us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-09-30 0001037646 us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember mtd:WesternEuropeanOperationsMember 2021-01-01 2021-09-30 0001037646 mtd:ChineseOperationsMember us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-09-30 0001037646 us-gaap:ServiceMember mtd:OtherOperationsMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-09-30 0001037646 us-gaap:ServiceMember us-gaap:TransferredAtPointInTimeMember 2021-01-01 2021-09-30 0001037646 us-gaap:ServiceMember mtd:USOperationsMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-09-30 0001037646 mtd:SwissOperationsMember us-gaap:ServiceMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-09-30 0001037646 us-gaap:ServiceMember mtd:WesternEuropeanOperationsMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-09-30 0001037646 mtd:ChineseOperationsMember us-gaap:ServiceMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-09-30 0001037646 us-gaap:ServiceMember mtd:OtherOperationsMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-09-30 0001037646 us-gaap:ServiceMember us-gaap:TransferredOverTimeMember 2021-01-01 2021-09-30 0001037646 mtd:USOperationsMember 2021-01-01 2021-09-30 0001037646 mtd:SwissOperationsMember 2021-01-01 2021-09-30 0001037646 mtd:WesternEuropeanOperationsMember 2021-01-01 2021-09-30 0001037646 mtd:ChineseOperationsMember 2021-01-01 2021-09-30 0001037646 mtd:OtherOperationsMember 2021-01-01 2021-09-30 0001037646 srt:AmericasMember 2022-07-01 2022-09-30 0001037646 srt:AmericasMember 2021-07-01 2021-09-30 0001037646 srt:AmericasMember 2022-01-01 2022-09-30 0001037646 srt:AmericasMember 2021-01-01 2021-09-30 0001037646 srt:EuropeMember 2022-07-01 2022-09-30 0001037646 srt:EuropeMember 2021-07-01 2021-09-30 0001037646 srt:EuropeMember 2022-01-01 2022-09-30 0001037646 srt:EuropeMember 2021-01-01 2021-09-30 0001037646 srt:AsiaMember 2022-07-01 2022-09-30 0001037646 srt:AsiaMember 2021-07-01 2021-09-30 0001037646 srt:AsiaMember 2022-01-01 2022-09-30 0001037646 srt:AsiaMember 2021-01-01 2021-09-30 0001037646 mtd:LaboratoryproductsandservicesMember 2022-09-30 utr:Rate 0001037646 mtd:IndustrialproductsandservicesMember 2022-09-30 0001037646 mtd:RetailproductsandservicesMember 2022-09-30 0001037646 mtd:LaboratoryproductsandservicesMember 2022-07-01 2022-09-30 0001037646 mtd:LaboratoryproductsandservicesMember 2021-07-01 2021-09-30 0001037646 mtd:LaboratoryproductsandservicesMember 2022-01-01 2022-09-30 0001037646 mtd:LaboratoryproductsandservicesMember 2021-01-01 2021-09-30 0001037646 mtd:IndustrialproductsandservicesMember 2022-07-01 2022-09-30 0001037646 mtd:IndustrialproductsandservicesMember 2021-07-01 2021-09-30 0001037646 mtd:IndustrialproductsandservicesMember 2022-01-01 2022-09-30 0001037646 mtd:IndustrialproductsandservicesMember 2021-01-01 2021-09-30 0001037646 mtd:RetailproductsandservicesMember 2022-07-01 2022-09-30 0001037646 mtd:RetailproductsandservicesMember 2021-07-01 2021-09-30 0001037646 mtd:RetailproductsandservicesMember 2022-01-01 2022-09-30 0001037646 mtd:RetailproductsandservicesMember 2021-01-01 2021-09-30 0001037646 us-gaap:DesignatedAsHedgingInstrumentMember mtd:November20212YRCrossCurrencySwapMember 2022-09-30 0001037646 us-gaap:DesignatedAsHedgingInstrumentMember mtd:June20214YRCrossCurrencySwapMember 2022-09-30 0001037646 us-gaap:DesignatedAsHedgingInstrumentMember mtd:June20213YRCrossCurrencySwapMember 2022-09-30 0001037646 us-gaap:DesignatedAsHedgingInstrumentMember mtd:June20194YRCrossCurrencySwapMember 2022-09-30 0001037646 us-gaap:DesignatedAsHedgingInstrumentMember mtd:A2.25100MillionInterestRateSwapMember 2022-09-30 0001037646 us-gaap:NondesignatedMember 2022-07-01 2022-09-30 0001037646 us-gaap:NondesignatedMember 2021-07-01 2021-09-30 0001037646 us-gaap:NondesignatedMember 2022-01-01 2022-09-30 0001037646 us-gaap:NondesignatedMember 2021-01-01 2021-09-30 0001037646 us-gaap:NondesignatedMember 2022-09-30 0001037646 us-gaap:NondesignatedMember 2021-12-31 0001037646 us-gaap:DesignatedAsHedgingInstrumentMember mtd:A2.5250MillionInterestRateSwapMember 2022-07-01 2022-09-30 0001037646 us-gaap:DesignatedAsHedgingInstrumentMember mtd:A2.5250MillionInterestRateSwapMember 2022-01-01 2022-09-30 0001037646 us-gaap:DesignatedAsHedgingInstrumentMember mtd:A2.25100MillionInterestRateSwapMember 2022-07-01 2022-09-30 0001037646 us-gaap:DesignatedAsHedgingInstrumentMember mtd:A2.25100MillionInterestRateSwapMember 2022-01-01 2022-09-30 0001037646 us-gaap:DesignatedAsHedgingInstrumentMember mtd:A2017CrossCurrencySwapMember 2022-07-01 2022-09-30 0001037646 us-gaap:DesignatedAsHedgingInstrumentMember mtd:A2017CrossCurrencySwapMember 2022-01-01 2022-09-30 0001037646 us-gaap:DesignatedAsHedgingInstrumentMember mtd:February2019CrossCurrencySwapMember 2022-07-01 2022-09-30 0001037646 us-gaap:DesignatedAsHedgingInstrumentMember mtd:February2019CrossCurrencySwapMember 2022-01-01 2022-09-30 0001037646 us-gaap:DesignatedAsHedgingInstrumentMember mtd:June20194YRCrossCurrencySwapMember 2022-07-01 2022-09-30 0001037646 us-gaap:DesignatedAsHedgingInstrumentMember mtd:June20194YRCrossCurrencySwapMember 2022-01-01 2022-09-30 0001037646 us-gaap:DesignatedAsHedgingInstrumentMember mtd:June20192YRCrossCurrencySwapMember 2022-07-01 2022-09-30 0001037646 us-gaap:DesignatedAsHedgingInstrumentMember mtd:June20192YRCrossCurrencySwapMember 2022-01-01 2022-09-30 0001037646 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001037646 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001037646 us-gaap:FairValueInputsLevel3Member 2021-03-24 xbrli:pure 0001037646 mtd:A367SeniorNotesMember mtd:UsDollarAmountsMember 2022-09-30 0001037646 mtd:OtherPrincipalTradingCurrenciesMember mtd:A367SeniorNotesMember 2022-09-30 0001037646 mtd:A367SeniorNotesMember 2022-09-30 0001037646 mtd:A4.10SeniorNotesMember mtd:UsDollarAmountsMember 2022-09-30 0001037646 mtd:OtherPrincipalTradingCurrenciesMember mtd:A4.10SeniorNotesMember 2022-09-30 0001037646 mtd:A4.10SeniorNotesMember 2022-09-30 0001037646 mtd:A3.84SeniorNotesMember mtd:UsDollarAmountsMember 2022-09-30 0001037646 mtd:A3.84SeniorNotesMember mtd:OtherPrincipalTradingCurrenciesMember 2022-09-30 0001037646 mtd:A3.84SeniorNotesMember 2022-09-30 0001037646 mtd:A4.24SeniorNotesMember mtd:UsDollarAmountsMember 2022-09-30 0001037646 mtd:A4.24SeniorNotesMember mtd:OtherPrincipalTradingCurrenciesMember 2022-09-30 0001037646 mtd:A4.24SeniorNotesMember 2022-09-30 0001037646 mtd:A3.91SeniorNotesMember mtd:UsDollarAmountsMember 2022-09-30 0001037646 mtd:OtherPrincipalTradingCurrenciesMember mtd:A3.91SeniorNotesMember 2022-09-30 0001037646 mtd:A3.91SeniorNotesMember 2022-09-30 0001037646 mtd:A283SeniorNotesMember mtd:UsDollarAmountsMember 2022-09-30 0001037646 mtd:A283SeniorNotesMember mtd:OtherPrincipalTradingCurrenciesMember 2022-09-30 0001037646 mtd:A283SeniorNotesMember 2022-09-30 0001037646 mtd:A3.19SeniorNotesMember mtd:UsDollarAmountsMember 2022-09-30 0001037646 mtd:A3.19SeniorNotesMember mtd:OtherPrincipalTradingCurrenciesMember 2022-09-30 0001037646 mtd:A3.19SeniorNotesMember 2022-09-30 0001037646 mtd:A281SeniorNoteMember mtd:UsDollarAmountsMember 2022-09-30 0001037646 mtd:A281SeniorNoteMember mtd:OtherPrincipalTradingCurrenciesMember 2022-09-30 0001037646 mtd:A281SeniorNoteMember 2022-09-30 0001037646 mtd:A1.47EUROSeniorNotesMember mtd:UsDollarAmountsMember 2022-09-30 0001037646 mtd:A1.47EUROSeniorNotesMember mtd:OtherPrincipalTradingCurrenciesMember 2022-09-30 0001037646 mtd:A1.47EUROSeniorNotesMember 2022-09-30 0001037646 mtd:A1.30EuroSeniorNotesMember mtd:UsDollarAmountsMember 2022-09-30 0001037646 mtd:OtherPrincipalTradingCurrenciesMember mtd:A1.30EuroSeniorNotesMember 2022-09-30 0001037646 mtd:A1.30EuroSeniorNotesMember 2022-09-30 0001037646 mtd:A106EuroSeniorNotesMember mtd:UsDollarAmountsMember 2022-09-30 0001037646 mtd:A106EuroSeniorNotesMember mtd:OtherPrincipalTradingCurrenciesMember 2022-09-30 0001037646 mtd:A106EuroSeniorNotesMember 2022-09-30 0001037646 mtd:UsDollarAmountsMember 2022-09-30 0001037646 mtd:OtherPrincipalTradingCurrenciesMember 2022-09-30 0001037646 mtd:OtherLocalArrangementsMember mtd:UsDollarAmountsMember 2022-09-30 0001037646 mtd:OtherLocalArrangementsMember mtd:OtherPrincipalTradingCurrenciesMember 2022-09-30 0001037646 mtd:OtherLocalArrangementsMember 2022-09-30 0001037646 mtd:SwissPensionLoansMember 2022-09-30 0001037646 mtd:A4.24SeniorNotesMember 2022-01-01 2022-09-30 0001037646 mtd:A367SeniorNotesMember 2022-01-01 2022-09-30 0001037646 mtd:A4.10SeniorNotesMember 2022-01-01 2022-09-30 0001037646 mtd:A3.84SeniorNotesMember 2022-01-01 2022-09-30 0001037646 mtd:A3.91SeniorNotesMember 2022-01-01 2022-09-30 0001037646 mtd:A3.19SeniorNotesMember 2022-01-01 2022-09-30 0001037646 mtd:A1.47EUROSeniorNotesMember 2022-01-01 2022-09-30 iso4217:EUR 0001037646 mtd:A1.30EuroSeniorNotesMember 2022-01-01 2022-09-30 0001037646 mtd:A283SeniorNotesMember 2022-01-01 2022-09-30 0001037646 us-gaap:LineOfCreditMember 2022-09-30 0001037646 us-gaap:LineOfCreditMember 2022-01-01 2022-09-30 0001037646 mtd:A281SeniorNoteMember 2022-01-01 2022-09-30 0001037646 mtd:A291SeniorNoteMember 2022-09-30 0001037646 mtd:A291SeniorNoteMember 2022-01-01 2022-09-30 0001037646 us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0001037646 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-12-31 0001037646 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-12-31 0001037646 us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-09-30 0001037646 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-01 2022-09-30 0001037646 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-01-01 2022-09-30 0001037646 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-09-30 0001037646 us-gaap:AccumulatedTranslationAdjustmentMember 2022-09-30 0001037646 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-09-30 0001037646 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-09-30 0001037646 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0001037646 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-12-31 0001037646 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-12-31 0001037646 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-09-30 0001037646 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-01 2021-09-30 0001037646 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-01-01 2021-09-30 0001037646 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-09-30 0001037646 us-gaap:AccumulatedTranslationAdjustmentMember 2021-09-30 0001037646 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-09-30 0001037646 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-09-30 0001037646 us-gaap:InterestRateSwapMember 2022-07-01 2022-09-30 0001037646 us-gaap:InterestRateSwapMember 2021-07-01 2021-09-30 0001037646 mtd:CrossCurrencySwapMember 2022-07-01 2022-09-30 0001037646 mtd:CrossCurrencySwapMember 2021-07-01 2021-09-30 0001037646 us-gaap:InterestRateSwapMember 2022-01-01 2022-09-30 0001037646 us-gaap:InterestRateSwapMember 2021-01-01 2021-09-30 0001037646 mtd:CrossCurrencySwapMember 2022-01-01 2022-09-30 0001037646 mtd:CrossCurrencySwapMember 2021-01-01 2021-09-30 0001037646 us-gaap:PensionPlansDefinedBenefitMember 2022-07-01 2022-09-30 0001037646 us-gaap:PensionPlansDefinedBenefitMember 2021-07-01 2021-09-30 0001037646 us-gaap:OtherPensionPlansDefinedBenefitMember 2022-07-01 2022-09-30 0001037646 us-gaap:OtherPensionPlansDefinedBenefitMember 2021-07-01 2021-09-30 0001037646 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-07-01 2022-09-30 0001037646 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-07-01 2021-09-30 0001037646 us-gaap:PensionPlansDefinedBenefitMember 2022-01-01 2022-09-30 0001037646 us-gaap:PensionPlansDefinedBenefitMember 2021-01-01 2021-09-30 0001037646 us-gaap:OtherPensionPlansDefinedBenefitMember 2022-01-01 2022-09-30 0001037646 us-gaap:OtherPensionPlansDefinedBenefitMember 2021-01-01 2021-09-30 0001037646 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2022-01-01 2022-09-30 0001037646 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2021-01-01 2021-09-30 0001037646 us-gaap:OtherPensionPlansDefinedBenefitMember 2022-09-30 0001037646 mtd:USOperationsMember 2022-07-01 2022-09-30 0001037646 mtd:USOperationsMember 2022-09-30 0001037646 mtd:SwissOperationsMember 2022-07-01 2022-09-30 0001037646 mtd:SwissOperationsMember 2022-09-30 0001037646 mtd:SegmentGeographicalGroupsOfCountriesGroupThreeMember 2022-07-01 2022-09-30 0001037646 mtd:SegmentGeographicalGroupsOfCountriesGroupThreeMember 2022-09-30 0001037646 mtd:SegmentGeographicalGroupsOfCountriesGroupFourMember 2022-07-01 2022-09-30 0001037646 mtd:SegmentGeographicalGroupsOfCountriesGroupFourMember 2022-09-30 0001037646 mtd:OtherOperationsMember 2022-07-01 2022-09-30 0001037646 mtd:OtherOperationsMember 2022-09-30 0001037646 us-gaap:IntersegmentEliminationMember 2022-07-01 2022-09-30 0001037646 us-gaap:IntersegmentEliminationMember 2022-09-30 0001037646 mtd:USOperationsMember 2022-01-01 2022-09-30 0001037646 mtd:SwissOperationsMember 2022-01-01 2022-09-30 0001037646 mtd:SegmentGeographicalGroupsOfCountriesGroupThreeMember 2022-01-01 2022-09-30 0001037646 mtd:SegmentGeographicalGroupsOfCountriesGroupFourMember 2022-01-01 2022-09-30 0001037646 mtd:OtherOperationsMember 2022-01-01 2022-09-30 0001037646 us-gaap:IntersegmentEliminationMember 2022-01-01 2022-09-30 0001037646 mtd:USOperationsMember 2021-07-01 2021-09-30 0001037646 mtd:USOperationsMember 2020-12-31 0001037646 mtd:SwissOperationsMember 2021-07-01 2021-09-30 0001037646 mtd:SwissOperationsMember 2020-12-31 0001037646 mtd:SegmentGeographicalGroupsOfCountriesGroupThreeMember 2021-07-01 2021-09-30 0001037646 mtd:SegmentGeographicalGroupsOfCountriesGroupThreeMember 2020-12-31 0001037646 mtd:SegmentGeographicalGroupsOfCountriesGroupFourMember 2021-07-01 2021-09-30 0001037646 mtd:SegmentGeographicalGroupsOfCountriesGroupFourMember 2020-12-31 0001037646 mtd:OtherOperationsMember 2021-07-01 2021-09-30 0001037646 mtd:OtherOperationsMember 2020-12-31 0001037646 us-gaap:IntersegmentEliminationMember 2021-07-01 2021-09-30 0001037646 us-gaap:IntersegmentEliminationMember 2020-12-31 0001037646 mtd:USOperationsMember 2021-01-01 2021-09-30 0001037646 mtd:SwissOperationsMember 2021-01-01 2021-09-30 0001037646 mtd:SegmentGeographicalGroupsOfCountriesGroupThreeMember 2021-01-01 2021-09-30 0001037646 mtd:SegmentGeographicalGroupsOfCountriesGroupFourMember 2021-01-01 2021-09-30 0001037646 mtd:OtherOperationsMember 2021-01-01 2021-09-30 0001037646 us-gaap:IntersegmentEliminationMember 2021-01-01 2021-09-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 10-Q

(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2022 , OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ____________ TO ________________
Commission File Number: 1-13595
Mettler Toledo International Inc
_______________________________________________________________________________________________________________________________________
(Exact name of registrant as specified in its charter)
Delaware 13-3668641
(State or other jurisdiction of (I.R.S Employer Identification No.)
incorporation or organization)
1900 Polaris Parkway
Columbus , OH 43240
and
Im Langacher, P.O. Box MT-100
CH 8606 Greifensee, Switzerland
1- 614 - 438-4511 and +41-44-944-22-11
________________________________________________________________________________
(Registrant's telephone number, including area code)

not applicable
______________________________________________________________________________________________________________________
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol Name of each exchange on which registered
Common Stock, $0.01 par value MTD New York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by checkmark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T ( § 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐
Indicate by checkmark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one): Large accelerated filer . ☒ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The Registrant had 22,294,189 shares of Common Stock outstanding at September 30, 2022.



METTLER-TOLEDO INTERNATIONAL INC.
INDEX TO QUARTERLY REPORT ON FORM 10-Q
PAGE


PART I. FINANCIAL INFORMATION
Item 1. Financial Statements

METTLER-TOLEDO INTERNATIONAL INC.
INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
Three months ended September 30, 2022 and 2021
(In thousands, except share data)
(unaudited)
September 30,
2022 		September 30,
2021
Net sales
Products $ 783,986 $ 760,844
Service 201,860 191,106
Total net sales 985,846 951,950
Cost of sales
Products 305,337 304,290
Service 95,853 91,840
Gross profit 584,656 555,820
Research and development 44,129 42,276
Selling, general and administrative 233,357 240,734
Amortization 16,728 16,039
Interest expense 14,484 11,791
Restructuring charges 2,022 650
Other charges (income), net ( 1,949 ) ( 3,257 )
Earnings before taxes 275,885 247,587
Provision for taxes 55,288 43,899
Net earnings $ 220,597 $ 203,688
Basic earnings per common share:
Net earnings $ 9.85 $ 8.83
Weighted average number of common shares 22,403,393 23,056,924
Diluted earnings per common share:
Net earnings $ 9.76 $ 8.71
Weighted average number of common and common equivalent shares 22,610,027 23,393,579
Comprehensive income, net of tax (Note 9) $ 178,448 $ 208,428


The accompanying notes are an integral part of these interim consolidated financial statements.
- 3 -
METTLER-TOLEDO INTERNATIONAL INC.
INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
Nine months ended September 30, 2022 and 2021
(In thousands, except share data)
(unaudited)
September 30,
2022 		September 30,
2021
Net sales
Products $ 2,270,845 $ 2,124,245
Service 591,179 556,446
Total net sales 2,862,024 2,680,691
Cost of sales
Products 902,445 843,613
Service 283,677 272,658
Gross profit 1,675,902 1,564,420
Research and development 131,180 124,151
Selling, general and administrative 710,875 701,531
Amortization 49,697 46,141
Interest expense 38,587 31,701
Restructuring charges 7,803 2,719
Other charges (income), net ( 7,818 ) ( 5,208 )
Earnings before taxes 745,578 663,385
Provision for taxes 138,910 125,271
Net earnings $ 606,668 $ 538,114
Basic earnings per common share:
Net earnings $ 26.86 $ 23.19
Weighted average number of common shares 22,587,026 23,203,257
Diluted earnings per common share:
Net earnings $ 26.58 $ 22.86
Weighted average number of common and common equivalent shares 22,821,408 23,536,615
Comprehensive income, net of tax (Note 9) $ 537,378 $ 575,187


The accompanying notes are an integral part of these interim consolidated financial statements.
- 4 -
METTLER-TOLEDO INTERNATIONAL INC.
INTERIM CONSOLIDATED BALANCE SHEETS
As of September 30, 2022 and December 31, 2021
(In thousands, except share data)
(unaudited)
September 30,
2022 		December 31,
2021
ASSETS
Current assets:
Cash and cash equivalents $ 122,136 $ 98,564
Trade accounts receivable, less allowances of $22,094 at September 30, 2022
and $22,176 at December 31, 2021 611,399 647,335
Inventories 451,320 414,543
Other current assets and prepaid expenses 131,047 108,916
Total current assets 1,315,902 1,269,358
Property, plant and equipment, net 728,602 799,365
Goodwill 636,089 648,622
Other intangible assets, net 297,435 307,450
Deferred tax assets, net 34,986 39,496
Other non-current assets 281,446 262,507
Total assets $ 3,294,460 $ 3,326,798
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Trade accounts payable $ 226,681 $ 272,911
Accrued and other liabilities 202,039 208,811
Accrued compensation and related items 184,773 236,265
Deferred revenue and customer prepayments 198,179 192,648
Taxes payable 199,626 134,769
Short-term borrowings and current maturities of long-term debt 153,639 101,134
Total current liabilities 1,164,937 1,146,538
Long-term debt 1,825,253 1,580,808
Deferred tax liabilities, net 76,532 62,230
Other non-current liabilities 310,547 365,801
Total liabilities 3,377,269 3,155,377
Commitments and contingencies (Note 14)
Shareholders’ equity:
Preferred stock, $0.01 par value per share; authorized 10,000,000 shares — —
Common stock, $0.01 par value per share; authorized 125,000,000 shares;
issued 44,786,011 and 44,786,011 shares; outstanding 22,294,189 shares and
22,843,103 shares at September 30, 2022 and December 31, 2021, respectively 448 448
Additional paid-in capital 842,421 825,974
Treasury stock at cost (22,491,822 shares at September 30, 2022 and 21,942,908 shares at December 31, 2021) ( 7,064,513 ) ( 6,259,049 )
Retained earnings 6,463,349 5,859,272
Accumulated other comprehensive loss ( 324,514 ) ( 255,224 )
Total shareholders' equity ( 82,809 ) 171,421
Total liabilities and shareholders’ equity $ 3,294,460 $ 3,326,798

The accompanying notes are an integral part of these interim consolidated financial statements.
- 5 -
METTLER-TOLEDO INTERNATIONAL INC.
INTERIM CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
Nine months ended September 30, 2022 and 2021
(In thousands, except share data)
(unaudited)
Additional Paid-in Capital Accumulated Other Comprehensive Income (Loss)
Common Stock Treasury Stock Retained Earnings
Shares Amount Total
Balance at December 31, 2020 23,471,841 $ 448 $ 805,140 $ ( 5,283,584 ) $ 5,095,596 $ ( 334,925 ) $ 282,675
Exercise of stock options and restricted stock units 22,388 — 1,239 4,682 ( 872 ) — 5,049
Repurchases of common stock ( 224,808 ) — — ( 262,500 ) — — ( 262,500 )
Share-based compensation — — 4,575 — — — 4,575
Net earnings — — — — 149,663 — 149,663
Other comprehensive income (loss), net of tax — — — — — 23,181 23,181
Balance at March 31, 2021 23,269,421 $ 448 $ 810,954 $ ( 5,541,402 ) $ 5,244,387 $ ( 311,744 ) $ 202,643
Exercise of stock options and restricted stock units 13,248 — — 2,849 ( 65 ) — 2,784
Repurchases of common stock ( 165,730 ) — — ( 212,499 ) — — ( 212,499 )
Share-based compensation — — 4,581 — — — 4,581
Net earnings — — — — 184,763 — 184,763
Other comprehensive income (loss), net of tax — — — — — 9,152 9,152
Balance at June 30, 2021 23,116,939 $ 448 $ 815,535 $ ( 5,751,052 ) $ 5,429,085 $ ( 302,592 ) $ 191,424
Exercise of stock options and restricted stock units 35,488 — — 7,889 ( 808 ) — 7,081
Repurchases of common stock ( 166,772 ) — — ( 252,499 ) — — ( 252,499 )
Share-based compensation — — 4,737 — — — 4,737
Net earnings — — — — 203,688 — 203,688
Other comprehensive income (loss), net of tax — — — — — 4,740 4,740
Balance at September 30, 2021 22,985,655 $ 448 $ 820,272 $ ( 5,995,662 ) $ 5,631,965 $ ( 297,852 ) $ 159,171
Balance at December 31, 2021 22,843,103 $ 448 $ 825,974 $ ( 6,259,049 ) $ 5,859,272 $ ( 255,224 ) $ 171,421
Exercise of stock options and restricted stock units 27,795 — 1,020 6,669 ( 2,400 ) — 5,289
Repurchases of common stock ( 190,593 ) — — ( 275,000 ) — — ( 275,000 )
Share-based compensation — — 4,509 — — — 4,509
Net earnings — — — — 174,001 — 174,001
Other comprehensive income (loss), net of tax — — — — — 4,350 4,350
Balance at March 31, 2022 22,680,305 $ 448 $ 831,503 $ ( 6,527,380 ) $ 6,030,873 $ ( 250,874 ) $ 84,570
Exercise of stock options and restricted stock units 44,613 — 1,496 10,925 — — 12,421
Repurchases of common stock ( 218,308 ) — — ( 274,999 ) — — ( 274,999 )
Share-based compensation — — 4,691 — — — 4,691
Net earnings — — — — 212,070 — 212,070
Other comprehensive income (loss), net of tax — — — — — ( 31,491 ) ( 31,491 )
Balance at June 30, 2022 22,506,610 $ 448 $ 837,690 $ ( 6,791,454 ) $ 6,242,943 $ ( 282,365 ) $ 7,262
Exercise of stock options and restricted stock units 8,058 — — 1,941 ( 191 ) — 1,750
Repurchases of common stock ( 220,479 ) — — ( 275,000 ) — — ( 275,000 )
Share-based compensation — — 4,731 — — — 4,731
Net earnings — — — — 220,597 — 220,597
Other comprehensive income (loss), net of tax — — — — — ( 42,149 ) ( 42,149 )
Balance at September 30, 2022 22,294,189 $ 448 $ 842,421 $ ( 7,064,513 ) $ 6,463,349 $ ( 324,514 ) $ ( 82,809 )

The accompanying notes are an integral part of these interim consolidated financial statements.
- 6 -
METTLER-TOLEDO INTERNATIONAL INC.
INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS
Nine months ended September 30, 2022 and 2021
(In thousands)
(unaudited)
September 30,
2022 		September 30,
2021
Cash flows from operating activities:
Net earnings $ 606,668 $ 538,114
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation 35,001 33,440
Amortization 49,697 46,141
Deferred tax benefit ( 4,881 ) ( 6,072 )
Share-based compensation 13,931 13,893
Increase (decrease) in cash resulting from changes in:
Trade accounts receivable, net ( 16,239 ) ( 19,153 )
Inventories ( 78,574 ) ( 87,568 )
Other current assets ( 14,509 ) ( 3,596 )
Trade accounts payable ( 26,614 ) 44,170
Taxes payable 73,815 42,474
Accruals and other ( 82,871 ) 65,876
Net cash provided by operating activities 555,424 667,719
Cash flows from investing activities:
Proceeds from sale of property, plant and equipment 236 3,399
Purchase of property, plant and equipment ( 89,213 ) ( 69,796 )
Proceeds from government funding 28,670 —
Acquisitions ( 25,588 ) ( 193,387 )
Other investing activities ( 3,463 ) 8,559
Net cash used in investing activities ( 89,358 ) ( 251,225 )
Cash flows from financing activities:
Proceeds from borrowings 1,732,169 1,638,321
Repayments of borrowings ( 1,348,152 ) ( 1,249,177 )
Proceeds from stock option exercises 19,460 14,914
Repurchases of common stock ( 824,999 ) ( 727,498 )
Acquisition contingent consideration payment ( 7,912 ) —
Other financing activities ( 1,172 ) ( 2,864 )
Net cash used in financing activities ( 430,606 ) ( 326,304 )
Effect of exchange rate changes on cash and cash equivalents ( 11,888 ) ( 772 )
Net increase (decrease) in cash and cash equivalents 23,572 89,418
Cash and cash equivalents:
Beginning of period 98,564 94,254
End of period $ 122,136 $ 183,672


The accompanying notes are an integral part of these interim consolidated financial statements.
- 7 -
METTLER-TOLEDO INTERNATIONAL INC.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)

1. BASIS OF PRESENTATION
Mettler-Toledo International Inc. (Mettler-Toledo or the Company) is a leading global supplier of precision instruments and services. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications. The Company also manufactures several related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development. In addition, the Company manufactures metal detection and other end-of-line inspection systems used in production and packaging and provides solutions for use in certain process analytics applications. The Company's primary manufacturing facilities are located in China, Germany, Switzerland, the United Kingdom and the United States. The Company's principal executive offices are located in Columbus, Ohio and Greifensee, Switzerland.
The accompanying interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) and include all entities in which the Company has control, which are its wholly-owned subsidiaries. The interim consolidated financial statements have been prepared without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. The interim consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.
The accompanying interim consolidated financial statements reflect all adjustments which, in the opinion of management, are necessary for a fair statement of the results of the interim periods presented. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the full year ending December 31, 2022.
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, as well as disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. These financial statements were prepared using information reasonably available as of September 30, 2022 and through the date of this report. Actual results may differ from those estimates due to the uncertainty around the global economy, the magnitude and duration of the COVID-19 pandemic, the ongoing developments related to Ukraine, as well as other factors.
All intercompany transactions and balances have been eliminated.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Trade Accounts Receivable
Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for expected credit losses represents the Company’s best estimate based on historical information, current information, and reasonable and supportable forecasts of future events and circumstances.
- 8 -
METTLER-TOLEDO INTERNATIONAL INC.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
Inventories
Inventories are valued at the lower of cost or net realizable value. Cost, which includes direct materials, labor and overhead, is generally determined using the first in, first out (FIFO) method. The estimated net realizable value is based on assumptions for future demand and related pricing. Adjustments to the cost basis of the Company’s inventory are made for excess and obsolete items based on usage, orders and technological obsolescence. If actual market conditions are less favorable than those projected by management, reductions in the value of inventory may be required.
Inventories consisted of the following:
September 30,
2022 		December 31,
2021
Raw materials and parts $ 215,397 $ 184,624
Work-in-progress 80,898 76,019
Finished goods 155,025 153,900
$ 451,320 $ 414,543
Goodwill and Other Intangible Assets
Goodwill, representing the excess of purchase price over the net asset value of companies acquired, and indefinite-lived intangible assets are not amortized, but are reviewed for impairment annually in the fourth quarter, or more frequently if events or changes in circumstances indicate that an asset might be impaired. The annual evaluation for goodwill and indefinite-lived intangible assets are generally based on an assessment of qualitative factors to determine whether it is more likely than not that the fair value of the asset is less than its carrying amount.
Other intangible assets include indefinite-lived assets and assets subject to amortization. Where applicable, amortization is charged on a straight-line basis over the expected period of benefit. The straight-line method of amortization reflects an appropriate allocation of the cost of the intangible assets to earnings in proportion to the amount of economic benefits obtained by the Company in each reporting period. The Company assesses the initial acquisition of intangible assets in accordance with the provisions of ASC 805 "Business Combinations" and the continued accounting for previously recognized intangible assets and goodwill in accordance with the provisions of ASC 350 "Intangible - Goodwill and Other" and ASC 360 "Property, Plant and Equipment".
Other intangible assets consisted of the following:
September 30, 2022 December 31, 2021
Gross
Amount 		Accumulated
Amortization 		Intangibles, Net Gross
Amount 		Accumulated
Amortization 		Intangibles, Net
Customer relationships $ 289,709 $ ( 88,707 ) $ 201,002 $ 282,470 $ ( 79,782 ) $ 202,688
Proven technology and patents 109,967 ( 60,200 ) $ 49,767 115,680 ( 56,305 ) 59,375
Tradenames (finite life) 7,490 ( 3,223 ) $ 4,267 8,206 ( 3,731 ) 4,475
Tradenames (indefinite life) 35,683 — $ 35,683 35,949 — 35,949
Other 13,242 ( 6,526 ) $ 6,716 10,641 ( 5,678 ) 4,963
$ 456,091 $ ( 158,656 ) $ 297,435 $ 452,946 $ ( 145,496 ) $ 307,450
- 9 -
METTLER-TOLEDO INTERNATIONAL INC.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
The Company recognized amortization expense associated with the above intangible assets of $ 6.7 million and $ 5.7 million for the three months ended September 30, 2022 and 2021, respectively, and $ 20.1 million and $ 15.9 million for the nine months ended September 30, 2022 and 2021, respectively. The annual aggregate amortization expense based on the current balance of other intangible assets is estimated to be $ 25.4 million for 2022, $ 23.6 million for 2023, $ 22.8 million for 2024, $ 21.9 million for 2025, $ 19.7 million for 2026, and $ 18.4 million for 2027. Purchased intangible amortization was $ 6.4 million, $ 5.0 million after tax, and $ 5.5 million, $ 4.1 million after tax, for the three months ended September 30, 2022 and 2021, respectively, and $ 19.4 million, $ 15.0 million after tax, and $ 15.2 million, $ 11.5 million after tax, for the nine months ended September 30, 2022 and 2021, respectively.
In addition to the above amortization, the Company recorded amortization expense associated with capitalized software of $ 10.0 million and $ 10.3 million for the three months ended September 30, 2022 and 2021, respectively, and $ 29.4 million and $ 30 million for the nine months ended September 30, 2022 and 2021, respectively.
Revenue Recognition
Product revenue is recognized from contracts with customers when a customer has obtained control of a product. The Company considers control to have transferred based upon shipping terms. To the extent the Company’s arrangements have a separate performance obligation, revenue related to any post-shipment performance obligation is deferred until completed. Shipping and handling costs charged to customers are included in total net sales and the associated expense is a component of cost of sales. Certain products are also sold through indirect distribution channels whereby the distributor assumes any further obligations to the end customer. Revenue is recognized on these distributor arrangements upon transfer of control to the distributor. Contracts do not contain variable pricing arrangements that are retrospective, except for rebate programs. Rebates are estimated based on expected sales volumes and offset against revenue at the time such revenue is recognized. The Company generally maintains the right to accept or reject a product return in its terms and conditions and also maintains appropriate accruals for outstanding credits. The related provisions for estimated returns and rebates are immaterial to the consolidated financial statements.
Certain of the Company’s product arrangements include separate performance obligations, primarily related to installation. Such performance obligations are accounted for separately when the deliverables have stand-alone value and the satisfaction of the undelivered performance obligations is probable and within the Company's control. The allocation of revenue between the performance obligations is based on the observable stand-alone selling prices at the time of the sale in accordance with a number of factors including service technician billing rates, time to install, and geographic location.
Software is generally not considered a distinct performance obligation with the exception of a few small software applications. The Company generally does not sell software products without the related hardware instrument as the software is embedded in the product. The Company’s products typically require no significant production, modification, or customization of the hardware or software that is essential to the functionality of the products.
Service revenue not under contract is recognized upon the completion of the service performed. Revenue from spare parts sold on a stand-alone basis is recognized when control is transferred to the customer, which is generally at the time of shipment or delivery. Revenue from service contracts is recognized ratably over the contract period using a time-based method. These contracts represent an obligation to perform repair and other services including regulatory compliance qualification, calibration, certification, and preventative maintenance on a customer’s pre-defined equipment over the contract period.

- 10 -
METTLER-TOLEDO INTERNATIONAL INC.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
Employee Termination Benefits
In situations where contractual termination benefits exist, the Company records accruals for employee termination benefits when it is probable that a liability has been incurred and the amount of the liability is reasonably estimable. All other employee termination arrangements are recognized and measured at their fair value at the communication date unless the employee is required to render additional service after the legal notification period, in which case the liability is recognized ratably over the future service period.
Share-Based Compensation
The Company recognizes share-based compensation expense within selling, general and administrative in the consolidated statements of operations and other comprehensive income with a corresponding offset to additional paid-in capital in the consolidated balance sheet. The Company recorded $ 4.7 million and $ 13.9 million of share-based compensation expense for the three and nine months ended September 30, 2022, respectively, compared to $ 4.7 million and $ 13.9 million for the corresponding periods in 2021.
Research and Development
Research and development costs primarily consist of salaries, consulting and other costs. The Company expenses these costs as incurred.

Business Combinations and Asset Acquisitions
The Company accounts for business acquisitions under the accounting standards for business combinations. The results of each acquisition are included in the Company's consolidated results as of the acquisition date. The purchase price of an acquisition is allocated to tangible and intangible assets and assumed liabilities based on their estimated fair values and any consideration in excess of the net assets acquired is recognized as goodwill. The determination of the values of the acquired assets and assumed liabilities, including goodwill and intangible assets, require significant judgment. Acquisition transaction costs are expensed when incurred.

In circumstances where an acquisition involves a contingent consideration arrangement, the Company recognizes a liability equal to the fair value of the expected contingent payments as of the acquisition date. Subsequent changes in the fair value of the contingent consideration are recorded to other charges (income), net.

Recent Accounting Pronouncements
In March 2020 and January 2021, the FASB issued ASU 2020-04 and ASU 2021-01: Reference Rate Reform which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by the discontinuance of LIBOR or another referenced rate. The guidance may be applied to any applicable contract entered into before December 31, 2022. The Company's interest rate and cross currency swaps, as mentioned in Note 4 to the consolidated financial statements, are governed by International Swaps and Derivatives Association ("ISDA") agreements, and the Company adheres to the ISDA's fallback protocol when LIBOR is discontinued. In addition, the Company renewed the LIBOR based credit agreement, as discussed further in Note 10 of the Annual Report Form 10-K, which includes a fallback protocol when LIBOR is discontinued. Based on these procedures, when LIBOR is discontinued the interest rate and cross currency swaps will not require de-designation if certain criteria are met. The Company expects the financial impact of the rate change when LIBOR is discontinued to be immaterial to its financial statements.

- 11 -
METTLER-TOLEDO INTERNATIONAL INC.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
3. REVENUE
The Company disaggregates revenue from contracts with customers by product, service, timing of revenue recognition and geography. A summary of revenue by the Company’s reportable segments for the three and nine months ended September 30, 2022 and 2021 follows:
For the three months ended September 30, 2022 U.S. Operations Swiss Operations Western European Operations Chinese Operations Other Operations Total
Product Revenue $ 287,948 $ 32,366 $ 129,089 $ 212,163 $ 122,421 $ 783,987
Service Revenue:
Point in time 65,596 6,401 29,071 13,543 30,248 144,859
Over time 20,220 2,205 22,799 4,016 7,760 57,000
Total $ 373,764 $ 40,972 $ 180,959 $ 229,722 $ 160,429 $ 985,846
For the three months ended September 30, 2021 U.S. Operations Swiss Operations Western European Operations Chinese Operations Other Operations Total
Product Revenue $ 263,885 $ 33,612 $ 142,318 $ 193,727 $ 127,302 $ 760,844
Service Revenue:
Point in time
56,325 6,092 37,524 12,680 30,120 142,741
Over time
16,498 2,146 18,790 4,053 6,878 48,365
Total $ 336,708 $ 41,850 $ 198,632 $ 210,460 $ 164,300 $ 951,950
For the nine months ended September 30, 2022 U.S. Operations Swiss Operations Western European Operations Chinese Operations Other Operations Total
Product Revenue $ 816,193 $ 99,567 $ 404,060 $ 593,283 $ 357,742 $ 2,270,845
Service Revenue:
Point in time 190,340 20,072 97,250 34,578 89,390 431,630
Over time 54,197 6,665 62,798 14,376 21,513 159,549
Total $ 1,060,730 $ 126,304 $ 564,108 $ 642,237 $ 468,645 $ 2,862,024
For the nine months ended September 30, 2021 U.S. Operations Swiss Operations Western European Operations Chinese Operations Other Operations Total
Product Revenue $ 721,744 $ 95,797 $ 424,904 $ 525,855 $ 355,945 $ 2,124,245
Service Revenue:
Point in time
162,409 19,517 110,243 34,655 87,708 414,532
Over time
47,824 6,653 57,557 11,545 18,335 141,914
Total $ 931,977 $ 121,967 $ 592,704 $ 572,055 $ 461,988 $ 2,680,691
A summary of revenue by major geographic destination for the three and nine months ended September 30 follows:
Three Months Ended Nine Months Ended
2022 2021 2022 2021
Americas $ 408,207 $ 367,278 $ 1,154,602 $ 1,024,033
Europe 228,145 258,925 720,667 760,491
Asia / Rest of World 349,494 325,747 986,755 896,167
Total $ 985,846 $ 951,950 $ 2,862,024 $ 2,680,691
- 12 -
METTLER-TOLEDO INTERNATIONAL INC.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
The Company's global revenue mix by product category is comprised of laboratory ( 56 % of sales), industrial ( 39 % of sales) and retail ( 5 % of sales). The Company's product revenue by reportable segment is proportionately similar to the Company's global mix except the Company's Swiss Operations is largely comprised of laboratory products while the Company's Chinese Operations has a slightly higher percentage of industrial products. A summary of the Company’s revenue by product category for the three and nine months ended September 30 is as follows:
Three Months Ended Nine Months Ended
2022 2021 2022 2021
Laboratory $ 555,112 $ 536,489 $ 1,614,586 $ 1,487,222
Industrial 386,543 370,505 1,114,454 1,049,295
Retail 44,191 44,956 132,984 144,174
Total $ 985,846 $ 951,950 $ 2,862,024 $ 2,680,691

The payment terms in the Company’s contracts with customers do not exceed one year and therefore contracts do not contain a significant financing component. In most cases, after appropriate credit evaluations, payments are due in arrears and are recognized as receivables. Unbilled revenue is recorded when performance obligations have been satisfied, but not yet billed to the customer. Unbilled revenue as of September 30, 2022 and December 31, 2021 was $ 34.7 million and $ 32.1 million, respectively, and is included within accounts receivable. Deferred revenue and customer prepayments are recorded when cash payments are received or due in advance of the performance obligation being satisfied. Deferred revenue primarily includes prepaid service contracts, as well as deferred installation.
Changes in the components of deferred revenue and customer prepayments during the nine month periods ending September 30, 2022 and 2021 are as follows:
2022 2021
Beginning balances as of January 1 $ 192,648 $ 149,106
Customer pre-payments/deferred revenue 545,997 496,437
Revenue recognized ( 523,022 ) ( 446,775 )
Foreign currency translation ( 17,444 ) ( 3,534 )
Ending balance as of September 30 $ 198,179 $ 195,234
The Company generally expenses sales commissions when incurred because the amortization period is one year or less. These costs are recorded within selling, general, and administrative expenses. The Company has not disclosed the value of unsatisfied performance obligations other than customer prepayments and deferred revenue above as most contracts have an expected length of one year or less and amounts greater than one year are immaterial.
- 13 -
METTLER-TOLEDO INTERNATIONAL INC.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
4. FINANCIAL INSTRUMENTS
The Company has limited involvement with derivative financial instruments and does not use them for trading purposes. The Company enters into certain interest rate and cross currency swap agreements in order to manage its exposure to changes in interest rates. The amount of the Company's fixed obligation interest payments may change based upon the expiration dates of its interest rate and cross currency swap agreements and the level and composition of its debt. The Company also enters into certain foreign currency forward contracts to limit the Company's exposure to currency fluctuations on the respective hedged items. For additional disclosures on derivative instruments regarding balance sheet location, fair value, and the amounts reclassified into other comprehensive income and the effective portion of the cash flow hedges, also see Note 5 and Note 9 to the interim consolidated financial statements. As also described in Note 7, the Company has designated its euro-denominated debt as a hedge of a portion of its net investment in euro-denominated foreign subsidiary.
Cash Flow Hedges
In November 2021, the Company entered into a cross currency swap arrangement designated as a cash flow hedge. The agreement converts $ 50 million of borrowings under the Company's credit facility into synthetic Swiss franc debt, which allows the Company to effectively change the floating rate LIBOR-based interest payments, excluding the credit spread, to a fixed Swiss franc income of 0.64 %. The swap matures in November 2023.
In June 2021, the Company entered into a cross currency swap arrangement designated as a cash flow hedge. The agreement converts $ 50 million of borrowings under the Company's credit facility into synthetic Swiss franc debt, which allows the Company to effectively change the floating rate LIBOR-based interest payments, excluding the credit spread to a fixed Swiss franc income of 0.57 %. The swap matures in June 2025.
In June 2021, the Company entered into a cross currency swap arrangement designated as a cash flow hedge. The agreement converts $ 50 million of borrowings under the Company's credit facility into synthetic Swiss franc debt, which allows the Company to effectively change the floating rate LIBOR-based interest payments, excluding the credit spread to a fixed Swiss franc income of 0.66 %. The swap matures in June 2024.
In June 2019, the Company entered into a cross currency swap arrangement designated as a cash flow hedge. The agreement converts $ 50 million of borrowings under the Company's credit facility into synthetic Swiss franc debt, which allows the Company to effectively change the floating rate LIBOR-based interest payments, excluding the credit spread to a fixed Swiss franc income of 0.82 %. The swap matures in June 2023.
In 2015, the Company entered into an interest rate swap agreement designated as a cash flow hedge. The agreement has the effect of changing the floating rate LIBOR-based interest payments associated with $ 100 million of borrowings under the Company's credit agreement to a fixed obligation of 2.25 % beginning in February 2017 and matured in February 2022.
The Company's cash flow hedges are recorded gross at fair value in the consolidated balance sheet at September 30, 2022 and December 31, 2021, respectively. A derivative gain of $ 7.2 million based upon interest rates and foreign currency rates at September 30, 2022, is expected to be reclassified from other comprehensive income (loss) to earnings in the next twelve months. The cash flow hedges remain effective as of September 30, 2022.


- 14 -
METTLER-TOLEDO INTERNATIONAL INC.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
Other Derivatives
The Company enters into foreign currency forward contracts in order to economically hedge short-term trade and non-trade intercompany balances largely denominated in Swiss franc, other major European currencies, and the Chinese Renminbi with its foreign businesses. In accordance with U.S. GAAP, these contracts are considered “derivatives not designated as hedging instruments.” Gains or losses on these instruments are reported in current earnings. The foreign currency forward contracts are recorded at fair value in the consolidated balance sheet at September 30, 2022 and December 31, 2021, respectively, and disclosed in Note 5. The Company recognized in other charges (income) related to these instruments, a net loss of $ 20.9 million and net gain of $ 3.3 million during the three months ended September 30, 2022 and 2021, respectively, and a net loss of $ 29.3 million and a net gain of $ 16.5 million during the nine months ended September 30, 2022 and 2021, respectively. The gains and losses are primarily offset by the underlying transaction gains and losses on the related intercompany balances. At September 30, 2022 and December 31, 2021, these contracts had a notional value of $ 757.5 million and $ 1.0 billion, respectively.
5. FAIR VALUE MEASUREMENTS
At September 30, 2022 and December 31, 2021, the Company had derivative assets totaling $ 20.5 million and $ 6.0 million respectively, and derivative liabilities totaling $ 12.2 million and $ 10.3 million, respectively. The Company has limited involvement with derivative financial instruments and therefore does not need to present all the required disclosures in tabular format. The fair values of the interest rate swap agreements, the cross-currency swap agreements and foreign currency forward contracts that economically hedge short-term intercompany balances are estimated based upon inputs from current valuation information obtained from dealer quotes and priced with observable market assumptions and appropriate valuation adjustments for credit risk. The Company has evaluated the valuation methodologies used to develop the fair values by dealers in order to determine whether such valuations are representative of an exit price in the Company’s principal market. In addition, the Company uses an internally developed model to perform testing on the valuations received from brokers. The Company has also considered both its own credit risk and counterparty credit risk in determining fair value and determined these adjustments were insignificant at September 30, 2022 and December 31, 2021.
Under U.S. GAAP, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A fair value measurement consists of observable and unobservable inputs that reflect the assumptions that a market participant would use in pricing an asset or liability.

A fair value hierarchy has been established that categorizes these inputs into three levels:
Level 1:    Quoted prices in active markets for identical assets and liabilities
Level 2:    Observable inputs other than quoted prices in active markets for identical assets and liabilities
Level 3:    Unobservable inputs
- 15 -
METTLER-TOLEDO INTERNATIONAL INC.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
The following table presents the Company's assets and liabilities, which are all categorized as Level 2, that are measured at fair value on a recurring basis. The Company does not have any assets or liabil ities which are categorized as Level 1 or Level 3, with the exception of the PendoTECH contingent consideration described below.
September 30, 2022 December 31, 2021 Balance Sheet Classification
Foreign currency forward contracts not designated as hedging instruments
$ 4,058 $ 3,927 Other current assets and prepaid expenses
Cash Flow Hedges:
Cross currency swap agreement
125 — Other current assets and prepaid expenses
Cross currency swap agreement
16,318 2,119 Other non-current assets
Total derivative assets $ 20,501 $ 6,046
Foreign currency forward contracts not designated as hedging instruments
$ 12,187 $ 4,510 Accrued and other liabilities
Cash Flow Hedges:
Interest rate swap agreements
— 352 Accrued and other liabilities
Cross currency swap agreement
— 5,482 Other non-current liabilities
Total derivative liabilities $ 12,187 $ 10,344
The Company had $ 26.6 million and $ 18.5 million of cash equivalents at September 30, 2022 and December 31, 2021, respectively, the fair value of which is determined using Level 2 inputs, through quoted and corroborated prices in active markets. The fair value of cash equivalents approximates cost.
The fair value of the Company's debt is less than the carrying value by approximately $ 242.3 million as of September 30, 2022. The fair value of the Company's fixed interest rate debt was estimated using Level 2 inputs, primarily discounted cash flow models, based on estimated current rates offered for similar debt under current market conditions for the Company.
During the nine months ended September 30, 2022, $10.0 million of contingent consideration was paid relating to the PendoTECH acquisition of which $7.9 million is included in financing activities for the amount accrued at the acquisition date and $2.1 million is included in operating activities for the amount not accrued at the acquisition date on the Consolidated Statement of Cash Flows in accordance with U.S. GAAP. The estimated fair value of the remaining contingent consideration obligation of $ 10.0 million is based upon actual results and future financial projections as of September 30, 2022. The fair value measurements are based on significant inputs not observable in the market and thus represent a Level 3 measurement.
6. INCOME TAXES
The Company's reported tax rate was 20.0 % and 17.7 % during the three months ended September 30, 2022 and 2021, respectively and 18.6 % and 18.9 % during the nine months ended September 30, 2022 and 2021, respectively. The provision for taxes is based upon using the Company's projected annual effective tax rate of 19.0 % and 19.5 % before non-recurring discrete tax items during 2022 and 2021, respectively. The difference between the Company's projected annual effective tax rate and the reported tax rate is primarily related to the timing of excess tax benefits associated with stock option exercises.
- 16 -
METTLER-TOLEDO INTERNATIONAL INC.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
7. DEBT
Debt consisted of the following at September 30, 2022:
U.S. Dollar Other Principal Trading Currencies Total
3.67% $50 million ten-year Senior Notes due December 17, 2022 $ 50,000 $ — $ 50,000
4.10% $50 million ten-year Senior Notes due September 19, 2023 50,000 — 50,000
3.84% $125 million ten-year Senior Notes due September 19, 2024 125,000 — 125,000
4.24% $125 million ten-year Senior Notes due June 25, 2025 125,000 — 125,000
3.91% $75 million ten-year Senior Notes due June 25, 2029 75,000 — 75,000
2.83% $125 million twelve-year Senior Notes due July 22, 2033 125,000 — 125,000
3.19% $50 million fifteen-year Senior Notes due January 24, 2035 50,000 — 50,000
2.81% $150 million fifteen-year Senior Note due March 17, 2037 150,000 — 150,000
2.91% $150 million fifteen-year Senior Note due September 1, 2037 150,000 — 150,000
1.47% Euro 125 million fifteen-year Senior Notes due June 17, 2030 — 120,301 120,301
1.30% Euro 135 million fifteen-year Senior Notes due November 6, 2034 — 129,925 129,925
1.06% Euro 125 million fifteen-year Senior Notes due March 19, 2036 — 120,301 120,301
Debt issuance costs, net ( 2,398 ) ( 1,521 ) ( 3,919 )
Total Senior Notes 897,602 369,006 1,266,608
$1.25 billion Credit Agreement, interest at LIBOR plus 87.5 basis points 495,806 159,149 654,955
Other local arrangements 4,563 52,766 57,329
Total debt 1,397,971 580,921 1,978,892
Less: current portion ( 100,983 ) ( 52,656 ) ( 153,639 )
Total long-term debt $ 1,296,988 $ 528,265 $ 1,825,253
As of September 30, 2022, the Company had $ 589.3 million of additional borrowings available under its Credit Agreement, and the Company maintained $ 122.1 million of cash and cash equivalents.
In December 2021, the Company entered into an agreement to issue and sell $300 million 15-year Senior Notes in a private placement. The Company issued $150 million with a fixed interest rate of 2.81% (2.81% Senior Notes) in March 2022 and an additional $150 million with a fixed interest rate of 2.91% (2.91% Senior Notes) in September 2022. The Senior Notes will be senior unsecured obligations of the Company. The 2.81% Senior Notes mature in March 2037 and the 2.91% Senior Notes mature in September 2037. Interest on the 2.81% and 2.91% Senior Notes will be payable semi-annually in March and September each year. Interest payments on the 2.81% Senior Notes will begin in September 2022 and interest on the 2.91% will begin in March 2023. The terms of the Senior Notes are consistent with the previous Senior Notes as described in the Company's Annual Report Form 10-K. The Company will use the proceeds from the sale of the notes to refinance existing indebtedness and for other general corporate purposes.
The Company has designated the EUR 125 million 1.47% Euro Senior Notes, the EUR 135 million 1.30% Euro Senior Notes, and the EUR 125 million 1.06% Euro Senior Notes as a hedge of a portion of its net investment in euro-denominated foreign subsidiaries to reduce foreign currency risk associated with the net investment. Changes in the carrying value of this debt resulting from fluctuations in the euro to U.S. dollar exchange rate are recorded as foreign currency translation adjustments within other comprehensive income (loss). The Company recorded in other comprehensive income (loss) related to this net investment hedge an unrealized gain of $ 35.8 million and an unrealized gain of $ 9.4 million for the
- 17 -
METTLER-TOLEDO INTERNATIONAL INC.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
three months ended September 30, 2022 and 2021, respectively, and an unrealized gain of $ 66.2 million and an unrealized gain of $ 21.2 million for the nine month periods ended September 30, 2022 and 2021, respectively. The Company has a gain of $ 71.7 million recorded in accumulated other comprehensive income (loss) as of September 30, 2022.

Other Local Arrangements
In April 2018, two of the Company's non-U.S. pension plans issued loans totaling $ 39.6 million (Swiss franc 38 million) to a wholly owned subsidiary of the Company. The loans have the same terms and conditions, which include an interest rate of SARON plus 87.5 basis points. The loans were renewed for one year in April 2022.

8. SHARE REPURCHASE PROGRAM AND TREASURY STOCK
In November 2022, the Company's Board of Directors authorized an additional $ 2.5 billion to be added to its share repurchase program, which has $ 1.2 billion of remaining availability as of September 30, 2022. The share repurchases are expected to be funded from cash generated from operating activities, borrowings, and cash balances. Repurchases will be made through open market transactions, and the amount and timing of purchases will depend on business and market conditions, the stock price, trading restrictions, the level of acquisition activity, and other factors.

The Company has purchased 30.8 million shares since the inception of the program in 2004 through September 30, 2022. During the nine months ended September 30, 2022 and 2021, the Company spent $ 825.0 million and $ 727.5 million on the repurchase of 629,380 shares and 557,310 shares at an average price per share of $ 1,310.79 and $ 1,305.35 , respectively. The Company also reissued 80,466 shares and 71,124 shares held in treasury upon the exercise of stock options and vesting of restricted stock units during the nine months ended September 30, 2022 and 2021, respectively.
9. ACCUMULATED OTHER COMPREHENSIVE INCOME
Comprehensive income (loss), net of tax consisted of the following as of September 30:
Three Months Ended Nine Months Ended
2022 2021 2022 2021
Net earnings $ 220,597 $ 203,688 $ 606,668 $ 538,114
Other comprehensive income (loss), net of tax ( 42,149 ) 4,740 ( 69,290 ) 37,073
Comprehensive income, net of tax $ 178,448 $ 208,428 $ 537,378 $ 575,187

The following table presents changes in accumulated other comprehensive income by component for the nine months ended September 30, 2022 and 2021:
- 18 -
METTLER-TOLEDO INTERNATIONAL INC.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
Currency Translation Adjustment, Net of Tax Net Unrealized
Gain (Loss) on
Cash Flow Hedging Arrangements,
Net of Tax 		Pension and Post-Retirement Benefit Related Items,
Net of Tax 		Total
Balance at December 31, 2021 $ ( 19,566 ) $ 2 $ ( 235,660 ) $ ( 255,224 )
Other comprehensive income (loss), net of tax:
Unrealized gains (losses) cash flow hedging arrangements
— 18,512 — 18,512
Foreign currency translation adjustment
( 101,250 ) — 17,842 ( 83,408 )
Amounts recognized from accumulated other comprehensive income (loss), net of tax
— ( 14,434 ) 10,040 ( 4,394 )
Net change in other comprehensive income (loss), net of tax
( 101,250 ) 4,078 27,882 ( 69,290 )
Balance at September 30, 2022 $ ( 120,816 ) $ 4,080 $ ( 207,778 ) $ ( 324,514 )
Currency Translation Adjustment, Net of Tax Net Unrealized
Gain (Loss) on
Cash Flow Hedging Arrangements,
Net of Tax 		Pension and Post-Retirement Benefit Related Items,
Net of Tax 		Total
Balance at December 31, 2020 $ ( 31,101 ) $ ( 1,479 ) $ ( 302,345 ) $ ( 334,925 )
Other comprehensive income (loss), net of tax:
Unrealized gains (losses) cash flow hedging arrangements
— 7,327 — 7,327
Foreign currency translation adjustment 8,102 — 12,062 20,164
Amounts recognized from accumulated other comprehensive income (loss), net of tax — ( 5,773 ) 15,355 9,582
Net change in other comprehensive income (loss), net of tax 8,102 1,554 27,417 37,073
Balance at September 30, 2021 $ ( 22,999 ) $ 75 $ ( 274,928 ) $ ( 297,852 )

The following table presents amounts recognized from accumulated other comprehensive income (loss) for the three and nine month periods ended September 30:
Three Months Ended
September 30,
2022 2021 Location of Amounts Recognized in Earnings
Effective portion of (gains) / losses on cash flow hedging arrangements:
Interest rate swap agreements
$ — $ 551 Interest expense
Cross currency swap agreement
( 7,612 ) ( 1,793 ) (a)
Total before taxes ( 7,612 ) ( 1,242 )
Provision for taxes ( 1,446 ) ( 201 ) Provision for taxes
Total, net of taxes $ ( 6,166 ) $ ( 1,041 )
Recognition of defined benefit pension and post-retirement items:
Recognition of actuarial losses and prior service cost, before taxes
$ 4,173 $ 6,449 (b)
Provision for taxes 896 1,361 Provision for taxes
Total, net of taxes $ 3,277 $ 5,088
- 19 -
METTLER-TOLEDO INTERNATIONAL INC.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
(a) The cross currency swap reflects an unrealized gain of $ 6.2 million for the three months ended September 30, 2022 recorded in other charges (income) that was offset by the underlying unrealized loss on the hedged debt. The cross currency swap also reflects a realized gain of $ 1.5 million recorded in interest expense for the three months ended September 30, 2022.
(b) These accumulated other comprehensive income (loss) components are included in the computation of net periodic pension and post-retirement cost. See Note 11 for additional details for the three months ended September 30, 2022 and 2021.
Nine Months Ended
September 30,
2022 2021 Location of Amounts Recognized in Earnings
Effective portion of (gains) / losses on cash flow hedging arrangements:
Interest rate swap agreements
$ 352 $ 1,625 Interest expense
Cross currency swap agreement
( 18,144 ) ( 8,625 ) (a)
Total before taxes ( 17,792 ) ( 7,000 )
Provision for taxes ( 3,358 ) ( 1,227 ) Provision for taxes
Total, net of taxes $ ( 14,434 ) $ ( 5,773 )
Recognition of defined benefit pension and post-retirement items:
Recognition of actuarial losses and prior service cost, before taxes
$ 12,788 $ 19,460 (b)
Provision for taxes 2,748 4,105 Provision for taxes
Total, net of taxes $ 10,040 $ 15,355
(a) The cross currency swap reflects an unrealized gain of $ 15.6 million for the nine months ended September 30, 2022 recorded in other charges (income) that was offset by the underlying unrealized loss on the hedged debt. The cross currency swap also reflects a realized gain of $ 2.6 million recorded in interest expense for the nine months ended September 30, 2022.
(b) These accumulated other comprehensive income (loss) components are included in the computation of net periodic pension and post-retirement cost. See Note 11 for additional details for the nine months ended September 30, 2022 and 2021 .

10. EARNINGS PER COMMON SHARE
In accordance with the treasury stock method, the Company has included the following common equivalent shares in the calculation of diluted weighted average number of common shares outstanding for the three and nine months ended September 30, relating to outstanding stock options and restricted stock units:
2022 2021
Three months ended 206,634 336,655
Nine months ended 234,382 333,358
Outstanding options and restricted stock units to purchase or receive 39,214 and 3,692 shares of common stock for the three month period ended September 30, 2022 and 2021, respectively, have been excluded from the calculation of diluted weighted average number of common and common equivalent shares as such options and restricted stock units would be anti-dilutive. Options and restricted stock units to purchase or receive 38,870 and 20,384 shares for the nine month period ended September 30, 2022 and 2021, respectively, have been excluded from the calculation of diluted weighted average of common and common equivalent shares as such options and restricted stock units would be anti-dilutive.
- 20 -
METTLER-TOLEDO INTERNATIONAL INC.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
11. NET PERIODIC PENSION COST
Net periodic pension cost for the Company’s defined benefit pension plans and U.S. post-retirement medical plan includes the following components for the three months ended September 30:
U.S. Pension Benefits Non-U.S. Pension Benefits Other U.S. Post-retirement Benefits Total
2022 2021 2022 2021 2022 2021 2022 2021
Service cost, net $ 416 $ 374 $ 4,732 $ 4,858 $ — $ — $ 5,148 $ 5,232
Interest cost on projected benefit obligations
674 546 1,447 843 3 2 2,124 1,391
Expected return on plan assets ( 1,548 ) ( 1,494 ) ( 8,951 ) ( 8,851 ) — — ( 10,499 ) ( 10,345 )
Recognition of prior service cost
— — ( 1,046 ) ( 462 ) ( 19 ) ( 18 ) ( 1,065 ) ( 480 )
Recognition of actuarial losses/(gains)
584 728 4,665 6,211 ( 8 ) ( 10 ) 5,241 6,929
Net periodic pension cost/(credit)
$ 126 $ 154 $ 847 $ 2,599 $ ( 24 ) $ ( 26 ) $ 949 $ 2,727

Net periodic pension cost for the Company’s defined benefit pension plans and U.S. post-retirement medical plan includes the following components for the nine months ended September 30:
U.S. Pension Benefits Non-U.S. Pension Benefits Other U.S. Post-retirement Benefits Total
2022 2021 2022 2021 2022 2021 2022 2021
Service cost, net $ 1,248 $ 1,122 $ 14,497 $ 14,710 $ — $ — $ 15,745 $ 15,832
Interest cost on projected benefit obligations
2,022 1,644 4,497 2,551 9 6 6,528 4,201
Expected return on plan assets ( 4,642 ) ( 4,482 ) ( 27,398 ) ( 26,726 ) — — ( 32,040 ) ( 31,208 )
Recognition of prior service cost — — ( 3,187 ) ( 1,398 ) ( 56 ) ( 56 ) ( 3,243 ) ( 1,454 )
Recognition of actuarial losses/(gains) 1,753 2,186 14,304 18,756 ( 23 ) ( 28 ) 16,034 20,914
Net periodic pension cost/(credit) $ 381 $ 470 $ 2,713 $ 7,893 $ ( 70 ) $ ( 78 ) $ 3,024 $ 8,285

As previously disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2021, the Company expects to make employer contributions of approximately $ 28.2 million to its non-U.S. pension plans during the year ended December 31, 2022. These estimates may change based upon several factors, including fluctuations in currency exchange rates, actual returns on plan assets and changes in legal requirements.

12. OTHER CHARGES (INCOME), NET
Other charges (income), net includes non-service pension costs (benefits), (gains) losses from foreign currency transactions and related hedging activities, interest income and other items. Non-service pension benefits for the three months ended September 30, 2022 and 2021 were $ 4.2 million and $ 2.5 million, respectively, and $ 12.7 million and $ 7.5 million for the nine months ended September 30, 2022 and 2021, respectively. Other charges (income), net also included $ 0.7 million and $ 2.8 million of acquisition costs for the nine months ended September 30, 2022 and 2021, respectively.
13.    SEGMENT REPORTING
As disclosed in Note 18 to the Company's consolidated financial statements for the year ended December 31, 2021, the Company has determined there are five reportable segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other.
- 21 -
METTLER-TOLEDO INTERNATIONAL INC.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
The Company evaluates segment performance based on Segment Profit (gross profit less research and development and selling, general and administrative expenses, before amortization, interest expense, restructuring charges, other charges (income), net and taxes).
The following tables show the operations of the Company’s operating segments:
Net Sales to Net Sales to As of September 30,
For the three months ended External Other Total Net Segment 2022
September 30, 2022 Customers Segments Sales Profit Goodwill
U.S. Operations $ 373,764 $ 35,077 $ 408,841 $ 93,823 $ 514,057
Swiss Operations 40,972 207,349 248,321 77,457 21,950
Western European Operations 180,959 49,486 230,445 38,950 86,222
Chinese Operations 229,722 79,285 309,007 123,345 606
Other (a) 160,429 705 161,134 20,603 13,254
Eliminations and Corporate (b) — ( 371,902 ) ( 371,902 ) ( 47,008 ) —
Total $ 985,846 $ — $ 985,846 $ 307,170 $ 636,089

Net Sales to Net Sales to
For the nine months ended External Other Total Net Segment
September 30, 2022 Customers Segments Sales Profit
U.S. Operations $ 1,060,730 $ 114,965 $ 1,175,695 $ 261,805
Swiss Operations 126,304 611,632 737,936 220,791
Western European Operations 564,108 147,087 711,195 112,963
Chinese Operations 642,237 234,847 877,084 313,769
Other (a) 468,645 2,377 471,022 63,298
Eliminations and Corporate (b) — ( 1,110,908 ) ( 1,110,908 ) ( 138,779 )
Total $ 2,862,024 $ — $ 2,862,024 $ 833,847

(a) Other includes reporting units in Eastern Europe, Latin America, Southeast Asia and other countries.
(b) Eliminations and Corporate includes the elimination of inter-segment transactions and certain corporate expenses and intercompany investments, which are not included in the Company’s operating segments.
Net Sales to Net Sales to As of September 30,
For the three months ended External Other Total Net Segment 2021
September 30, 2021 Customers Segments Sales Profit Goodwill
U.S. Operations $ 336,708 $ 36,895 $ 373,603 $ 72,638 $ 508,942
Swiss Operations 41,850 208,411 250,261 78,454 23,319
Western European Operations 198,632 52,259 250,891 40,288 91,228
Chinese Operations 210,460 79,001 289,461 108,636 696
Other (a) 164,300 835 165,135 24,381 14,999
Eliminations and Corporate (b) — ( 377,401 ) ( 377,401 ) ( 51,587 ) —
Total $ 951,950 $ — $ 951,950 $ 272,810 $ 639,184
- 22 -
METTLER-TOLEDO INTERNATIONAL INC.
NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(In thousands, except share data, unless otherwise stated)
Net Sales to Net Sales to
For the nine months ended External Other Total Net Segment
September 30, 2021 Customers Segments Sales Profit
U.S. Operations $ 931,977 $ 112,186 $ 1,044,163 $ 215,581
Swiss Operations 121,967 594,057 716,024 212,849
Western European Operations 592,704 160,386 753,090 116,630
Chinese Operations 572,055 220,608 792,663 275,323
Other (a) 461,988 3,207 465,195 65,967
Eliminations and Corporate (b) — ( 1,090,444 ) ( 1,090,444 ) ( 147,612 )
Total $ 2,680,691 $ — $ 2,680,691 $ 738,738

(a) Other includes reporting units in Eastern Europe, Latin America, Southeast Asia and other countries.
(b) Eliminations and Corporate includes the elimination of inter-segment transactions and certain corporate expenses and intercompany investments, which are not included in the Company’s operating segments.
A reconciliation of earnings before taxes to segment profit for the three and nine month periods ended September 30 follows:
Three Months Ended Nine Months Ended
2022 2021 2022 2021
Earnings before taxes $ 275,885 $ 247,587 $ 745,578 $ 663,385
Amortization 16,728 16,039 49,697 46,141
Interest expense 14,484 11,791 38,587 31,701
Restructuring charges 2,022 650 7,803 2,719
Other income, net ( 1,949 ) ( 3,257 ) ( 7,818 ) ( 5,208 )
Segment profit $ 307,170 $ 272,810 $ 833,847 $ 738,738



14. CONTINGENCIES
The Company is party to various legal proceedings, including certain environmental matters, incidental to the normal course of business. Management does not expect that any of such proceedings, either individually or in the aggregate, will have a material adverse effect on the Company’s financial condition, results of operations or cash flows.
- 23 -
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the Unaudited Interim Consolidated Financial Statements included herein.
General
Our interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the full year ending December 31, 2022.
Changes in local currency exclude the effect of currency exchange rate fluctuations. Local currency amounts are determined by translating current and previous year consolidated financial information at an index utilizing historical currency exchange rates. We believe local currency information provides a helpful assessment of business performance and a useful measure of results between periods. We do not, nor do we suggest that investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. We present non-GAAP financial measures in reporting our financial results to provide investors with an additional analytical tool to evaluate our operating results.
We also include in the discussion below disclosures of immaterial qualitative factors that are not quantified. Although the impact of such factors is not considered material, we believe these disclosures can be useful in evaluating our operating results.
COVID-19
Since late 2019, the coronavirus pandemic (COVID-19) has spread globally in all countries where we conduct business. The COVID-19 pandemic is evolving and has led to the implementation of various responses, including government-imposed quarantines, stay-at-home orders and lockdowns, travel restrictions, vaccination and testing requirements, and other public health safety measures. These restrictions continue to change as COVID-19 evolves, variants and subvariants are discovered, and vaccinations and booster doses are distributed in each country and region. The emergence of COVID-19 variants and subvariants have presented particular challenges to the global economy given the high level of transmissibility, which can cause many people to be affected at the same time or over a short period of time. For example, China continues to institute lockdowns in certain cities as part of the government's response to COVID-19 outbreaks. The location and length of potential future lockdowns will determine the extent to which any lockdowns impact our business and supply chain, as well as the Chinese and global economies. We continue to monitor and comply with all global restrictions and requirements relating to COVID-19.
The health and safety of our employees and business partners have been our highest priority throughout the COVID-19 pandemic, and we have implemented several preventative and protective measures. We also have continued to support our customers with their essential businesses, such as life sciences, food manufacturing, chemicals (e.g., sanitizers, disinfectants, soaps, etc.), food retail, and transportation and logistics.
Our production and logistics facilities are currently operational, and our employees continue to adhere to any applicable jurisdictional lockdowns and stay-at-home orders. Our supply chain is currently facing wide-ranging global challenges, although we have been able to meet delivery requirements of our customers with some interruption. We continue to closely monitor risks associated with our supply chain, including ongoing and potential future lockdowns in China, availability of certain components, material shortages, supplier delays, potential transportation delays, and higher transportation and material costs, which could significantly adversely affect sales and/or profitability in future quarters. We also continue to leverage our digital and remote sales capabilities, and our service organization continues to provide on-site and remote customer support to facilitate uptime, productivity, and regulatory compliance.
- 24 -
COVID-19 presents several risks to our business as further described in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2021. Uncertainties related to COVID-19 and the resulting impact to the global economy continue in most regions of the world and market conditions can change quickly. The longer-term effects on our business will be impacted by the global economy and any recession implications in different regions of the world.
Ongoing Developments Related to Ukraine
In 2021, approximately 1% of our net sales were in Russia and Ukraine, and we have an immaterial amount of assets and liabilities in both countries as of September 30, 2022. We also do not have manufacturing in Russia or Ukraine.
We remain in constant contact with our employees in Ukraine and have provided financial assistance and supplies as they seek safety. We also have suspended all shipments to Russia since the beginning of the invasion of Ukraine in February 2022. In addition, the U.S., the European Union, and certain other countries imposed economic sanctions on Russian financial institutions, businesses in Russia, and on Russian interests and individuals, and the Russian government implemented sanctions and regulations in response. Also, due to the impact of reduced energy supplies from Russia, the Council of the European Union (EU Council) proposed that all European member states strive for a voluntary 15% reduction in gas consumption compared to their average consumption over the last five years. The reduction timeframe commenced August 1, 2022 and is expected to continue through March 31, 2023. Accordingly, the availability and cost of energy will continue to be impacted.
While it is difficult to estimate the impact of the ongoing invasion on the global economy, including increased inflation, higher energy and transportation costs and potential energy shortages, the invasion of Ukraine could adversely impact our financial results and presents several risks to our business as further described in Part II, Item 1A, “Risk Factors” of this Quarterly Report. Uncertainties related to this conflict and the resulting impact to the global economy and market conditions can change quickly.
Results of Operations – Consolidated
The following tables set forth certain items from our interim consolidated statements of operations for the three and nine month periods ended September 30, 2022 and 2021 (amounts in thousands).
Three months ended September 30, Nine months ended September 30,
2022 2021 2022 2021
(unaudited) % (unaudited) % (unaudited) % (unaudited) %
Net sales $ 985,846 100.0 $ 951,950 100.0 $ 2,862,024 100.0 $ 2,680,691 100.0
Cost of sales 401,190 40.7 396,130 41.6 1,186,122 41.4 1,116,271 41.6
Gross profit 584,656 59.3 555,820 58.4 1,675,902 58.6 1,564,420 58.4
Research and development 44,129 4.5 42,276 4.4 131,180 4.6 124,151 4.6
Selling, general and administrative 233,357 23.7 240,734 25.3 710,875 24.8 701,531 26.2
Amortization 16,728 1.7 16,039 1.7 49,697 1.7 46,141 1.7
Interest expense 14,484 1.5 11,791 1.2 38,587 1.3 31,701 1.2
Restructuring charges 2,022 0.2 650 0.1 7,803 0.3 2,719 0.1
Other charges (income), net (1,949) (0.3) (3,257) (0.3) (7,818) (0.2) (5,208) (0.2)
Earnings before taxes 275,885 28.0 247,587 26.0 745,578 26.1 663,385 24.8
Provision for taxes 55,288 5.6 43,899 4.6 138,910 4.9 125,271 4.7
Net earnings $ 220,597 22.4 $ 203,688 21.4 $ 606,668 21.2 $ 538,114 20.1

Net sales
Net sales were $985.8 million and $952.0 million for the three months ended September 30, 2022, and 2021, respectively, and $2.9 billion and $2.7 billion for the nine months ended September 30, 2022 and 2021, respectively. This represents an increase of 4% and 7% in U.S. dollars for the three and nine months ended September 30, 2022, respectively. Excluding the effect
- 25 -
of currency exchange rate fluctuations, or in local currencies, net sales increased 10% and 11% for the three and nine months ended September 30, 2022, respectively. We experienced strong growth in most businesses with excellent execution and lower growth in Europe. We continue to benefit from our best-in-class sales and marketing programs, innovative product portfolio, and investments in our field service organization. However, uncertainties exist in the macro environment and global economy including the impact of COVID-19, related lockdowns in China, and the impact from the ongoing developments related to Ukraine. Furthermore, we face continuing challenges in the global supply chain and inflationary cost increases, and market conditions may change quickly.
Net sales by geographic destination for the three months ended September 30, 2022 in U.S. dollars increased 11% in the Americas and 7% in Asia/Rest of World and decreased 12% in Europe. In local currencies, our net sales by geographic destination increased 11% in the Americas, 1% in Europe, and 15% in Asia/Rest of World. Our net sales by geographic destination for the nine months ended September 30, 2022 in U.S. dollars increased 13% in the Americas and 10% in Asia/Rest of World and decreased 5% in Europe. Net sales by geographic destination for the nine months ended September 30, 2022 in local currencies increased 13% in the Americas, 5% in Europe, and 15% in Asia/Rest of World. Net sales in the Americas benefited approximately 1% from the PendoTECH acquisition for the nine months ended September 30, 2022. Net sales growth in Asia/Rest of World in local currency includes 15% growth in China during the three and nine months ended September 30, 2022. A discussion of sales by operating segment is included below.
As described in Note 18 to our consolidated financial statements for the year ended December 31, 2021, our net sales comprise product sales of precision instruments and related services. Service revenues are primarily derived from repair and other services, including regulatory compliance qualification, calibration, certification, preventative maintenance and spare parts.
Net sales of products increased 3% in U.S. dollars and 9% in local currencies for the three months ended September 30, 2022 and increased 7% in U.S. dollars and 11% in local currencies for the nine months ended September 30, 2022, compared to the corresponding periods in 2021. Service revenue (including spare parts) increased by 6% in U.S. dollars and 13% in local currencies for the three months ended September 30, 2022 and increased 6% in U.S. dollars and 12% in local currencies for the nine months ended September 30, 2022, compared to the corresponding periods in 2021.
Net sales of our laboratory products and services, which represented approximately 56% of our total net sales, increased 3% in U.S. dollars and 10% in local currencies for the three months ended September 30, 2022, and increased 9% in U.S. dollars and 13% in local currencies for the nine months ended September 30, 2022. The local currency increase in net sales of our laboratory-related products for the three and nine months ended September 30, 2022 includes very strong growth in most product categories. Net sales of our laboratory products also benefited approximately 1% from the PendoTECH acquisition for the nine months ended September 30, 2022.
Net sales of our industrial products and services, which represented approximately 39% of our total net sales, increased 4% in U.S. dollars and 10% in local currencies for the three months ended September 30, 2022, and increased 6% in U.S. dollars and 10% in local currencies for the nine months ended September 30, 2022. The local currency increase in net sales of our industrial-related products for the three and nine months ended September 30, 2022 includes very strong growth in our core industrial business, especially in the U.S. and China.
Net sales in our food retailing products and services, which represented approximately 5% of our total net sales, decreased 2% in U.S. dollars and increased 7% in local currencies for the three months ended September 30, 2022, and decreased 8% in U.S. dollars and 2% in local currencies for the nine months ended September 30, 2022. Food retailing for the three months ended September 30, 2022 included very strong growth in the Americas, offset in part by reduced sales in China. The local currency decrease in net sales in our food retailing products for the nine months ended September 30, 2022 was negatively impacted by weak market dynamics, especially in China, offset in part by very strong growth in the Americas.
- 26 -
Gross profit
Gross profit as a percentage of net sales was 59.3% and 58.4% for the three months ended September 30, 2022 and 2021, respectively, and 58.6% and 58.4% for the nine months ended September 30, 2022 and 2021, respectively.
Gross profit as a percentage of net sales for products was 61.1% and 60.0% for the three months ended September 30, 2022 and 2021, respectively, and 60.3% and 60.3% for the nine months ended September 30, 2022 and 2021.
Gross profit as a percentage of net sales for services (including spare parts) was 52.5% and 51.9% for the three months ended September 30, 2022 and 2021, respectively, and 52.0% and 51.0% for the nine months ended September 30, 2022 and 2021, respectively.
The increase in gross profit as a percentage of net sales for the three and nine months ended September 30, 2022 primarily reflects favorable price realization and increased sales volume, offset in part by higher material costs.
Research and development and selling, general and administrative expenses
Research and development expenses as a percentage of net sales was 4.5% and 4.4% for the three months ended September 30, 2022 and 2021, respectively, and was 4.6% for the nine months ended September 30, 2022 and 2021. Research and development expenses increased 4% in U.S. dollars and 10% in local currencies for the three months ended September 30, 2022, and increased 6% in U.S. dollars and 10% in local currencies for the nine months ended September 30, 2022, respectively, compared to the corresponding periods in 2021. The local currency increase primarily relates to increased project activity.
Selling, general and administrative expenses as a percentage of net sales were 23.7% and 25.3% for the three months ended September 30, 2022 and 2021, respectively, and were 24.8% and 26.2% for the nine months ended September 30, 2022 and 2021, respectively. Selling, general and administrative expenses decreased 3% in U.S. dollars and increased 3% in local currencies for the three months ended September 30, 2022, and increased 1% in U.S. dollars and 6% in local currencies for the nine months ended September 30, 2022. The local currency increase includes investments in sales and marketing.
Amortization, interest expense, restructuring charges, other charges (income), net and taxes
Amortization expense was $16.7 million and $16.0 million for the three months ended September 30, 2022 and 2021, respectively, and $49.7 million and $46.1 million for the nine months ended September 30, 2022 and 2021, respectively.
Interest expense was $14.5 million and $11.8 million for the three months ended September 30, 2022 and 2021, respectively, and $38.6 million and $31.7 million for the nine months ended September 30, 2022 and 2021, respectively.
Restructuring charges were $2.0 million and $0.7 million for the three months ended September 30, 2022 and 2021, respectively, and $7.8 million and $2.7 million for the nine months ended September 30, 2022 and 2021, respectively. Restructuring expenses are primarily comprised of employee-related costs.
Other charges (income), net includes non-service pension costs (benefits), net (gains) losses from foreign currency transactions and hedging activities, interest income and other items. Non-service pension benefits were $4.2 million and $2.5 million for the three months ended September 30, 2022 and 2021, respectively, and $12.7 million and $7.5 million and for the nine months ended September 30, 2022 and 2021, respectively. Other charges (income), net also included $0.7 million and $2.8 million of acquisition costs for the nine months ended September 30, 2022 and 2021, respectively.
- 27 -
Our reported tax rate was 20.0% and 17.7% during the three months ended September 30, 2022 and 2021, respectively, and 18.6% and 18.9% during the nine months ended September 30, 2022 and 2021, respectively. The provision for taxes is based upon using our projected annual effective tax rate of 19% and 19.5% before non-recurring discrete tax items for the periods ended September 30, 2022 and 2021, respectively. The difference between our projected annual effective tax rate and the reported tax rate is related to the timing of excess tax benefits associated with stock option exercises.
Results of Operations – by Operating Segment
The following is a discussion of the financial results of our operating segments. We currently have five reportable segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. A more detailed description of these segments is outlined in Note 18 to our consolidated financial statements for the year ended December 31, 2021.
U.S. Operations (amounts in thousands)
Three months ended September 30, Nine months ended September 30,
2022 2021 % 2022 2021 %
Total net sales $ 408,841 $ 373,603 9% $ 1,175,695 $ 1,044,163 13%
Net sales to external customers $ 373,764 $ 336,708 11% $ 1,060,730 $ 931,977 14%
Segment profit $ 93,823 $ 72,638 29% $ 261,805 $ 215,581 21%

Total net sales increased 9% and 13% for the three and nine months ended September 30, 2022, respectively, compared with the corresponding periods in 2021. Net sales to external customers increased 11% and 14% for the three and nine months ended September 30, 2022, respectively, compared with the corresponding periods in 2021. Net sales to external customers for the three and nine months ended September 30, 2022 includes strong growth in most product categories, particularly industrial and food retailing. Net sales to external customers in our U.S. Operations also benefited approximately 1% from the PendoTECH acquisition for the nine months ended September 30, 2022.
Segment profit increased $21.2 million and $46.2 million for the three and nine months ended September 30, 2022, respectively, compared to the corresponding periods in 2021. Segment profit during the three and nine months ended September 30, 2022 includes higher net sales volume and benefits from our margin expansion initiatives, offset in part by higher material costs.
Swiss Operations (amounts in thousands)
Three months ended September 30, Nine months ended September 30,
2022 2021
% 1)
2022 2021
% 1)
Total net sales $ 248,321 $ 250,261 (1)% $ 737,936 $ 716,024 3%
Net sales to external customers $ 40,972 $ 41,850 (2)% $ 126,304 $ 121,967 4%
Segment profit $ 77,457 $ 78,454 (1)% $ 220,791 $ 212,849 4%
1) Represents U.S. dollar growth (decline) for net sales and segment profit.
Total net sales decreased 1% in U.S. dollars and increased 4% in local currency for the three months ended September 30, 2022, and increased 3% in U.S. dollars and 7% in local currency for the nine months ended September 30, 2022, respectively, compared to the corresponding periods in 2021. Net sales to external customers decreased 2% in U.S. dollars and increased 1% in local currency for the three months ended September 30, 2022 and increased 4% in U.S. dollars and 7% in local currency for the nine months ended September 30, 2022, compared to the corresponding periods in 2021. The increase in local currency net sales to external customers for the three and nine months ended September 30, 2022 includes growth in laboratory and industrial products.
- 28 -
Segment profit decreased $1.0 million and increased $7.9 million the three and nine months ended September 30, 2022, compared to the corresponding periods in 2021. Segment profit during the nine months ended September 30, 2022 includes higher net sales volume and benefits from our margin expansion initiatives, offset in part by unfavorable foreign currency translation and higher material costs.
Western European Operations (amounts in thousands)
Three months ended September 30, Nine months ended September 30,
2022 2021
% 1)
2022 2021
% 1)
Total net sales $ 230,445 $ 250,891 (8)% $ 711,195 $ 753,090 (6)%
Net sales to external customers $ 180,959 $ 198,632 (9)% $ 564,108 $ 592,704 (5)%
Segment profit $ 38,950 $ 40,288 (3)% $ 112,963 $ 116,630 (3)%
1) Represents U.S. dollar growth (decline) for net sales and segment profit.

Total net sales decreased 8% in U.S. dollars and increased 8% in local currencies for the three months ended September 30, 2022 and decreased 6% in U.S. dollars and increased 6% in local currencies for the nine months ended September 30, 2022, compared to the corresponding periods in 2021. Net sales to external customers decreased 9% in U.S. dollars and increased 7% in local currencies for the three months ended September 30, 2022, and decreased 5% in U.S. dollars and increased 7% in local currencies for the nine months ended September 30, 2022, compared to the corresponding periods in 2021. The increase in local currency net sales to external customers for the three and nine months ended September 30, 2022 includes solid growth in most product categories, especially laboratory and core-industrial products. Net sales to external customers for the three months ended September 30, 2022 includes declines in pipettes and product inspection.
Segment profit decreased $1.3 million and $3.7 million for the three and nine month periods ended September 30, 2022, respectively, compared to the corresponding periods in 2021. Segment profit decreased during the three and nine months ended September 30, 2022 primarily due to unfavorable currency translation and higher material costs, offset in part by higher sales volume and benefits from our margin expansion initiatives.
Chinese Operations (amounts in thousands)
Three months ended September 30, Nine months ended September 30,
2022 2021
% 1)
2022 2021
% 1)
Total net sales $ 309,007 $ 289,461 7% $ 877,084 $ 792,663 11%
Net sales to external customers $ 229,722 $ 210,460 9% $ 642,237 $ 572,055 12%
Segment profit $ 123,345 $ 108,636 14% $ 313,769 $ 275,323 14%
1) Represents U.S. dollar growth for net sales and segment profit.

Total net sales increased 7% in U.S. dollars and 13% in local currency for the three months ended September 30, 2022 and increased 11% in U.S. dollars and 13% in local currency for the nine months ended September 30, 2022, compared to the corresponding periods in 2021. Net sales to external customers increased 9% in U.S. dollars and 15% in local currency by origin for the three months ended September 30, 2022 and increased 12% in U.S. dollars and 15% in local currency during the nine months ended September 30, 2022, compared to the corresponding periods in 2021. Net sales to external customers during the three and nine months ended September 30, 2022 includes very strong growth in laboratory and core-industrial products, offset in part by a decline in food retailing. However, uncertainties exist, especially relating to potential additional COVID-19 lockdowns and the related impact on the economy, and market conditions may change quickly.
Segment profit increased $14.7 million and $38.4 million for the three and nine month periods ended September 30, 2022, respectively, compared to the corresponding periods in 2021.
- 29 -
The increase in segment profit for the three and nine months ended September 30, 2022 primarily reflects increased sales volume and benefits from our margin expansion initiatives, offset in part by unfavorable currency translation and higher material costs.
Other (amounts in thousands)
Three months ended September 30, Nine months ended September 30,
2022 2021
% 1)
2022 2021
% 1)
Total net sales $ 161,134 $ 165,135 (2)% $ 471,022 $ 465,195 1%
Net sales to external customers $ 160,429 $ 164,300 (2)% $ 468,645 $ 461,988 1%
Segment profit $ 20,603 $ 24,381 (15)% $ 63,298 $ 65,967 (4)%
1) Represents U.S. dollar growth for net sales and segment profit.

Net sales to external customers decreased 2% in U.S. dollars and increased 7% in local currencies for the three months ended September 30, 2022 and increased 1% in U.S. dollars and 9% in local currencies for the nine months ended September 30, 2022, compared to the corresponding periods in 2021. The increase in net sales to external customers for the three and nine months ended September 30, 2022 includes particularly strong growth in laboratory products.
Segment profit decreased $3.8 million and $2.7 million for the three and nine months ended September 30, 2022, respectively, compared to the corresponding periods in 2021. The decrease in segment profit for the three and nine months ended September 30, 2022 is primarily related to unfavorable foreign currency translation and higher material costs, offset by increased sales volume.
Liquidity and Capital Resources
Liquidity is our ability to generate sufficient cash flows from operating activities to meet our obligations and commitments. In addition, liquidity includes available borrowings under our Credit Agreement, the ability to obtain appropriate financing and our cash and cash equivalent balances. Currently, our liquidity needs are primarily driven by working capital requirements, capital expenditures, share repurchases and acquisitions. Global market conditions can be uncertain, and our ability to generate cash flow could be reduced by a deterioration in global markets.
We currently believe that cash flows from operating activities, together with liquidity available under our Credit Agreement, local working capital facilities, and cash balances, will be sufficient to fund currently anticipated working capital needs and spending requirements for at least the foreseeable future.
Cash provided by operating activities totaled $555.4 million during the nine months ended September 30, 2022, compared to $667.7 million in the corresponding period in 2021. The decrease for the nine months ended September 30, 2022 is primarily related to higher cash incentive payments related to our strong previous year performance, as well as increased inventory levels.
Capital expenditures are made primarily for investments in information systems and technology, machinery, equipment and the purchase and expansion of facilities. Our capital expenditures totaled $89.2 million for the nine months ended September 30, 2022 compared to $69.8 million in the corresponding period in 2021.
In September 2021, we entered into an agreement with the U.S. Department of Defense to increase domestic production capacity of pipette tips and enhance manufacturing automation and logistics. As of September 30, 2022, we have obtained $28.7 million of the $35.8 million of total funding to be received through 2023, which will offset associated capital expenditures. During the nine months ended September 30, 2022, we incurred approximately $28.6 million of capital expenditures relating to this funding agreement.
We continue to explore potential acquisitions. In connection with any acquisition, we may incur additional indebtedness. During the nine months ended September 30, 2022, $10.0 million of
- 30 -
contingent consideration was paid relating to the PendoTECH acquisition of which $7.9 million is included in financing activities for the amount accrued at the acquisition date and $2.1 million is included in operating activities for the amount not accrued at the acquisition date on the Consolidated Statement of Cash Flows in accordance with U.S. GAAP.

In 2022, we also incurred acquisition payments totaling $25.6 million. Goodwill recorded in connection with these acquisitions totaled $8.9 million. We also recorded $10.7 million of identified intangibles primarily pertaining to customer relationships in connection with these acquisitions, which will be amortized on a straight-line basis over 10 to 15 years.
Cash flows used in financing activities are primarily comprised of share repurchases. In accordance with our share repurchase program, we spent $825.0 million and $727.5 million on the repurchase of 629,380 shares and 557,310 shares, during the nine months ended September 30, 2022 and 2021, respectively.
The Inflation Reduction Act (IRA) was enacted on August 16, 2022. The IRA includes provisions imposing a 1% excise tax on net share repurchases that occur after December 31, 2022 and introduces a 15% corporate alternative minimum tax (CAMT) on adjusted financial statement income. We expect the financial impact of the IRA to be immaterial to our financial statements.
Senior Notes and Credit Facility Agreement
Our debt consisted of the following at September 30, 2022:
U.S. Dollar Other Principal Trading Currencies Total
3.67% $50 million ten-year Senior Notes due December 17, 2022 $ 50,000 $ — $ 50,000
4.10% $50 million ten-year Senior Notes due September 19, 2023 50,000 — 50,000
3.84% $125 million ten-year Senior Notes due September 19, 2024 125,000 — 125,000
4.24% $125 million ten-year Senior Notes due June 25, 2025 125,000 — 125,000
3.91% $75 million ten-year Senior Notes due June 25, 2029 75,000 — 75,000
2.83% $125 million twelve-year Senior Notes due July 22, 2033 125,000 — 125,000
3.19% $50 million fifteen-year Senior Notes due January 24, 2035 50,000 — 50,000
2.81% $150 million fifteen-year Senior Note due March 17, 2037 150,000 — 150,000
2.91% $150 million fifteen-year Senior Note due September 1, 2037 150,000 — 150,000
1.47% Euro 125 million fifteen-year Senior Notes due June 17, 2030 — 120,301 120,301
1.30% Euro 135 million fifteen-year Senior Notes due November 6, 2034 — 129,925 129,925
1.06% Euro 125 million fifteen-year Senior Notes due March 19, 2036 — 120,301 120,301
Debt issuance costs, net (2,398) (1,521) (3,919)
Total Senior Notes 897,602 369,006 1,266,608
$1.25 billion Credit Agreement, interest at LIBOR plus 87.5 basis points 495,806 159,149 654,955
Other local arrangements 4,563 52,766 57,329
Total debt 1,397,971 580,921 1,978,892
Less: current portion (100,983) (52,656) (153,639)
Total long-term debt $ 1,296,988 $ 528,265 $ 1,825,253
As of September 30, 2022, approximately $589.3 million of additional borrowings was available under our Credit Agreement, and we maintained $122.1 million of cash and cash equivalents.
Changes in exchange rates between the currencies in which we generate cash flows and the currencies in which our borrowings are denominated affect our liquidity. In addition, because we borrow in a variety of currencies, our debt balances fluctuate due to changes in exchange rates.
- 31 -
Further, we do not have any downgrade triggers relating to ratings from rating agencies that would accelerate the maturity dates of our debt. We were in compliance with our debt covenants as of September 30, 2022.
In December 2021, we entered into an agreement to issue and sell $300 million 15-year Senior Notes in a private placement. We issued $150 million with a fixed interest rate of 2.81% (2.81% Senior Notes) in March 2022, which will mature in March 2037, and an additional $150 million with a fixed interest rate of 2.91% (2.91% Senior Notes) in September 2022, which will mature in September 2037. We will use the proceeds from the sale of the notes to refinance existing indebtedness and for other general corporate purposes.
Other Local Arrangements
In April 2018, two of our non-U.S. pension plans issued loans totaling $39.6 million (Swiss franc 38 million) to a wholly owned subsidiary of the Company. The loans have the same terms and conditions which include an interest rate of SARON plus 87.5 basis points. The loans were renewed for one year in April 2022.
Share Repurchase Program
In November 2022, our Board of Directors authorized an additional $2.5 billion to be added to our share repurchase program, which has $1.2 billion of remaining availability as of September 30, 2022. The share repurchases are expected to be funded from cash generated from operating activities, borrowings, and cash balances. Repurchases will be made through open market transactions, and the amount and timing of purchases will depend on business and market conditions, the stock price, trading restrictions, the level of acquisition activity, and other factors.
We have purchased 30.8 million shares since the inception of the program through September 30, 2022. During the nine months ended September 30, 2022 and 2021, we spent $825.0 million and $727.5 million on the repurchase of 629,380 and 557,310 shares at an average price per share of $1,310.79 and $1,305.35, respectively. We also reissued 80,466 shares and 71,124 shares held in treasury upon the exercise of stock options and vesting of restricted stock units during the nine months ended September 30, 2022 and 2021, respectively.
Effect of Currency on Results of Operations
Our earnings are affected by changes in exchange rates. We are most sensitive to changes in the exchange rates between the Swiss franc, euro, Chinese renminbi, and U.S. dollar. We have more Swiss franc expenses than we do Swiss franc sales because we develop and manufacture products in Switzerland that we sell globally, and have a number of corporate functions located in Switzerland. When the Swiss franc strengthens against our other trading currencies, particularly the U.S. dollar and euro, our earnings decrease. We also have significantly more sales in the euro than we do expenses. When the euro weakens against the U.S. dollar and Swiss franc, our earnings also decrease. We estimate a 1% strengthening of the Swiss franc against the euro would reduce our earnings before tax by approximately $1.9 million to $2.1 million annually.
We also conduct business in many geographies throughout the world, including Asia Pacific, the United Kingdom, Eastern Europe, Latin America, and Canada. Fluctuations in these currency exchange rates against the U.S. dollar can also affect our operating results. The most significant of these currency exposures is the Chinese renminbi. The impact on our earnings before tax of the Chinese renminbi weakening 1% against the U.S. dollar is a reduction of approximately $3.5 million to $3.7 million annually.
In addition to the effects of exchange rate movements on operating profits, our debt levels can fluctuate due to changes in exchange rates, particularly between the U.S. dollar, the Swiss franc and the euro. Based on our outstanding debt at September 30, 2022, we estimate that a 5% weakening of the U.S. dollar against the currencies in which our debt is denominated would result in an increase of approximately $30.7 million in the reported U.S. dollar value of our debt.
- 32 -
Forward-Looking Statements Disclaimer
You should not rely on forward-looking statements to predict our actual results. Our actual results or performance may be materially different than reflected in forward-looking statements because of various risks and uncertainties, including statements about expected revenue growth and long-term impacts of the COVID-19 pandemic and ongoing developments related to Ukraine. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “potential” or “continue.”
We make forward-looking statements about future events or our future financial performance, including earnings and sales growth, earnings per share, strategic plans and contingency plans, growth opportunities or economic downturns, our ability to respond to changes in market conditions, customer demand, our competitive position, pricing, our supply chain, adequacy of our facilities, access to and the costs of raw materials, shipping and supplier costs, gross margins, planned research and development efforts and product introductions, capital expenditures, cash flow, tax-related matters, the impact of foreign currencies, compliance with laws, effects of acquisitions, and the impact of the COVID-19 pandemic and ongoing developments related to Ukraine on our businesses.
Our forward-looking statements may not be accurate or complete, and we do not intend to update or revise them in light of actual results. New risks also periodically arise. Please consider the risks and factors that could cause our results to differ materially from what is described in our forward-looking statements, including the uncertain duration and severity of the COVID-19 pandemic and ongoing developments related to Ukraine. See in particular “Factors Affecting Our Future Operating Results” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2021 and other reports filed with the SEC from time to time.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
As of September 30, 2022, there was no material change in the information provided under Item 7A in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.
Item 4. Controls and Procedures
Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures as required by Exchange Act Rule 13a-15(b) as of the end of the period covered by this report. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer, have concluded that these disclosure controls and procedures are effective. There were no changes in our internal control over financial reporting during the quarter ended September 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

- 33 -
PART II. OTHER INFORMATION

Item 1. Legal Proceedings. None
Item 1A. Risk Factors.
For the three and nine months ended September 30, 2022 there were no material changes from risk factors disclosed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, and as updated in the Company's Form 10-Q for the period ended June 30, 2022.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Issuer Purchases of Equity Securities
(a) (b) (c) (d)
Total Number of
Shares Purchased 		Average Price Paid
per Share 		Total Number of
Shares Purchased as Part of Publicly Announced Program 		Approximate Dollar
Value (in thousands) of Shares that may yet be Purchased under the Program
July 1 to July 31, 2022 69,336 $ 1,189.72 69,336 $ 1,425,938
August 1 to August 31, 2022 78,525 $ 1,329.46 78,525 $ 1,321,540
September 1 to September 30, 2022 72,618 $ 1,213.32 72,618 $ 1,233,430
Total 220,479 $ 1,247.26 220,479 $ 1,233,430

In November 2022, the Company's Board of Directors authorized an additional $2.5 billion to be added to its share repurchase program, which has $1.2 billion of remaining availability as of September 30, 2022. We have purchased 30.8 million shares since the inception of the program through September 30, 2022.
During the nine months ended September 30, 2022 and 2021, we spent $825.0 million and $727.5 million on the repurchase of 629,380 and 557,310 shares at an average price per share of $1,310.79 and $1,305.35, respectively. We also reissued 80,466 shares and 71,124 shares held in treasury upon the exercise of stock options and vesting of restricted stock units during the nine months ended September 30, 2022 and 2021, respectively.

Item 3. Defaults Upon Senior Securities. None
Item 5.    Other information. None
Item 6.    Exhibits. See Exhibit Index.

- 34 -
EXHIBIT INDEX
Exhibit No. Description
101.INS* XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH* XBRL Taxonomy Extension Schema Document
101.CAL* XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB* XBRL Taxonomy Extension Label Linkbase Document
101.PRE* XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF* XBRL Taxonomy Extension Definition Linkbase Document
_______________________
*    Filed herewith
- 35 -
SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Mettler-Toledo International Inc.
Date: November 4, 2022 By: /s/ Shawn P. Vadala
Shawn P. Vadala
Chief Financial Officer

- 36 -
TABLE OF CONTENTS